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Abstract 
The g-ratio, quantifying the comparative thickness of the myelin sheath encasing an axon, 
is a geometrical invariant that has high functional relevance because of its importance in 
determining neuronal conduction velocity. Advances in MRI data acquisition and signal 
modelling have put in vivo mapping of the g-ratio, across the entire white matter, within 
our reach. This capacity would greatly increase our knowledge of the nervous system: 
how it functions, and how it is impacted by disease. This is the second review on the topic 
of g-ratio mapping using MRI. As such, it summarizes the most recent developments in 
the field, while also providing methodological background pertinent to aggregate g-ratio 
weighted mapping, and discussing pitfalls associated with these approaches. Using 
simulations based on recently published data, this review demonstrates the relevance of 
the calibration step for three myelin-markers (macromolecular tissue volume, myelin 
water fraction, and bound pool fraction). It highlights the need to estimate both the slope 
and offset of the relationship between these MRI-based markers and the true myelin 
volume fraction if we are really to achieve the goal of precise, high sensitivity g-ratio 
mapping in vivo. Other challenges discussed in this review further evidence the need for 
gold standard measurements of human brain tissue from ex vivo histology. We conclude 
that the quest to find the most appropriate MRI biomarkers to enable in vivo g-ratio 
mapping is ongoing, with the potential of many novel techniques yet to be investigated.   
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1 Introduction 
The g-ratio is a geometrical invariant of axons quantifying their degree of myelination 
relative to their cross-sectional size. Coupled with the axonal diameter, the g-ratio is a 
key determinate of neuronal conduction velocity (Rushton, 1951; Chomiak and Hu, 2009; 
Schmidt and Knösche, 2019). Signal transmission along different axonal fibres can be 
regulated and synchronised by varying the degree of myelination, and therefore the g-
ratio, to optimize cognitive function, sensory integration and motor skills (Fields, 2015). 
As the central nervous system appears to communicate at physical limits to constrain 
metabolic demands (Salami et al., 2003; Hartline and Colman, 2007; Coggan et al., 
2015), small deviations from the optimal g-ratio value (0.6-0.8, (Rushton, 1951; Chomiak 
and Hu, 2009)) may have strong functional impact. For example, histological investigation 
has shown that the cortical g-ratio is higher in patients with multiple sclerosis, probably 
because of the de- and re-myelination processes associated with the disease and its 
progression (Albert et al., 2007). To understand such processes and their functional 
implications, clinical research and diagnostics would benefit greatly from the capacity to 
measure the g-ratio of fibre pathways in vivo.  
Until recently, information about the g-ratio distributions have only been accessible by 
invasive methods such as ex vivo electron microscopy (Hildebrand and Hahn, 1978), 
which restricted analyses to small numbers of axons and a limited number of brain regions 
or pathways. The g-ratio measured by such techniques is denoted the microscopic g-ratio 
because of the extremely fine spatial resolution that can be achieved. Clearly using MRI 
to investigate the g-ratio in vivo would be highly desirable as it could provide whole brain 
information on a voxel-wise basis. Stikov et al. proposed the methodology by which such 
a non-invasive MR-based “aggregate” g-ratio could be measured (Stikov et al., 2011, 
2015), which we denote in this review interchangeably the “MR g-ratio” or “g-ratio 
mapping”. The MR g-ratio framework measures the ensemble average of an underlying, 
unresolved, microstructural distribution of g-ratios. Making a strong assumption that the 
g-ratio is constant within a voxel, Stikov et al. demonstrated, via a geometrical plausibility 
argument (Stikov et al., 2011, 2015), that this aggregate MR g-ratio can be computed on 
a voxel-wise basis from the ratio of the myelin and axonal volume fractions (MVF and 
AVF respectively). Establishing this relation was important because both the MVF and 
AVF can be estimated by combining biophysical models (Alexander et al., 2019; Novikov 
et al., 2019) and quantitative MRI within a framework known as in vivo histology using 
MRI (Weiskopf et al., 2015). 
The challenge for, and validity of, in vivo g-ratio mapping centres on how precisely and 
accurately the AVF and MVF can be measured with the chosen MRI techniques. Three 
years ago, Campbell et al. thoroughly reviewed the methods of g-ratio mapping and 
highlighted potential pitfalls (Campbell et al., 2018). A key take home message of their 
review was the introduction of the qualifying term “weighted” into the name MR g-ratio, 
i.e. aggregated g-ratio weighted mapping.  They proposed this qualifier to acknowledge 
the impact that any miscalibration between the MR-based myelin proxy and the true MVF 
would have.  Typically, ex vivo electron microscopy measures of the MVF act as the gold 
standard for methodological assessment and calibration. 
Despite the challenges associated with accurate measurement and calibration of the MVF 
and AVF, many studies have exploited the potential of in vivo g-ratio weighted imaging 
for a variety of different applications (see Table 1 for full details).  These have ranged 
from g-ratio mapping in infants (Melbourne et al., 2016) and children (Dean et al., 2016) 
to healthy adults (Mohammadi et al., 2015; Mancini et al., 2018; Berman et al., 2019; 
Drakesmith et al., 2019), during healthy aging (Cercignani et al., 2017; Berman et al., 
2018) and as a result of pathological change (Hagiwara et al., 2017; Hori et al., 2018; 
Kamagata et al., 2019; Yu et al., 2019).  
Since the review by Campbell et al. (Campbell et al., 2018), awareness has increased 
regarding the fact that g-ratio mapping with MRI can be confounded by the degree of 
miscalibration of the MRI-based MVF proxy. Furthermore, new methodological studies 
have been published on g-ratio weighted mapping, e.g. to assess its repeatability (Duval 
et al., 2018; Ellerbrock and Mohammadi, 2018a), and the reproducibility when the 
particular proxies used for the AVF and MVF are varied (Ellerbrock and Mohammadi, 
2018a). A series of validation studies have also been conducted by the Does lab (Kelm 
et al., 2016; West et al., 2018a, 2018b) based on extensive histological data coupled with 
ex vivo MRI.  These studies have provided insight into the relationship between the MR 
g-ratio, and the various MVF measures through comparison with the current gold 
standard of electron microscopy. A particular strength of these studies has been the 
inherently large dynamic range of the MVF and g-ratio owing to the fact that hyper- and 
hypo-myelinating mouse models were used. This has enabled the validity and sensitivity 
of g-ratio mapping to be more thoroughly investigated. 
In this review, we provide the background information necessary to understand the MRI 
methodologies that have been used to date to quantify the MVF and AVF (or fibre volume 
fraction, FVF) in vivo specifically in the context of g-ratio mapping. We seek to unify the 
nomenclature describing the various myelin and diffusion models.  Moreover, we use the 
findings of the aforementioned methodological studies in simulation based experiments 
to further understand the impact on the MR g-ratio of currently used calibration methods. 
We examine the accuracy of the estimates based on the three myelin markers most 
commonly used for g-ratio mapping: the bound pool fraction derived, from quantitative 
magnetisation transfer methods, the macromolecular tissue volume derived from proton 
density mapping, and the myelin water fraction derived from myelin water imaging. 
Finally, we provide an outlook on emerging approaches and what will be required to make 
g-ratio mapping with MRI a viable clinical tool. 
 Biomarkers Subjects or 
Participants 
Remarks 
 Axonal or 
Fibre volume 
fraction (AVF 
or FVF)  
Myelin 
volume 
fraction 
(MVF) 
 LA.x and LM.x refer to 
limitations pertinent, 
respectively, to the AVF 
or MVF measure used. 
(Stikov et 
al., 2011) 
DWI1 (DTI) SPGR (qMT) 5C First model relating g-
ratio to MVF and AVF. It 
assumed constant g-ratio 
in a voxel, and parallel 
axons. FA was also 
related to FVF assuming 
parallel fibres. LA.1, 
LM.1, LM.9 
(Stikov et 
al., 2015) 
DWI2.5 
(NODDI) 
SPGR (qMT) 1C; 1P; 1Mc;  Revised g-ratio model. In 
this model, the g-ratio is 
still assumed to be 
constant in a voxel but 
the model was extended 
to nonparallel axons. 
LA.3,LA.4,LM.1, LM.9 
(Mohamm
adi et al., 
2015) 
DWI1 (TFD) MPM with 
multi-echo 
SPGR 
(MTsat) 
36C First group study on g-
ratio mapping using the 
MPM and DTI protocol as 
biomarkers for MVF and 
FVF. LA.2, LM.1, LM.2, 
LM.9 
(West et 
al., 2016) 
- - 6M Revised MR g-ratio 
model validated on 
volume fractions from 
electron microscopy, 
revealing that the MR g-
ratio is an area-weighted 
average of the 
microscopic g-ratio.   
(Melbourn
e et al., 
2016) 
DWI2 
(NODDI) 
2D GRASE 
(MET2) 
37PI  The g-ratio of preterm 
infants scanned (27 and 
58 weeks). LA.3, LA.4, 
LM.6, LM.7 
(Dean et 
al., 2016) 
DWI2 
(NOODI) 
SPGR & 
bSSFP 
(mcDESPOT) 
18I g-ratio index changes 
across childhood 
(3 months to 7.5 years of 
age).LA.3, LA.4, LM.3, 
LM.9 
(Hagiwara 
et al., 
2017) 
DWI2 
(NODDI) 
SyMRI 20P g-ratio index in multiple 
sclerosis patients. MVF 
was estimated via the 
SyMRI model (Warntjes 
et al., 2016). LA.3, LA.4, 
LM.10 
(Duval et 
al., 2017) 
DWI20 
(CHARMED) 
SPGR (MTV) 9C g-ratio index in human 
spinal cord. LA.6, LM.4, 
LM.1, LM.9 
(Cercignan
i et al., 
2017) 
DWI2.4 
(NODDI) 
bSSFP (qMT) 38C qMT was calculated via 
in-house software. B1+ 
correction was not 
reported.  Change of g-
ratio as a function of age. 
LA.3,LA.4, LM.1, LM.9 
(Ellerbrock 
and 
Mohamma
di, 2018a) 
DWI1 (TFD), 
DWI2 
(NODDI) 
MPM with 
multi-echo 
SPGR 
(MTsat, MTV) 
12C, 10C Four different g-ratio 
index maps were 
compared in a scan-
rescan experiment 
between two groups of 
subjects (12 and 10 
subjects). LA.2, LA.3, 
LA.4, LM.1, LM.2, LM.9 
(Berman et 
al., 2018) 
DWI1 (DTI) SPGR (MTV) 92C; M15* Change of g-ratio as a 
function of age. LA.1, 
LM.1, LM.4, LM.9 
(Duval et 
al., 2018) 
As in (Stikov 
et al., 2011) 
SPGR (MTV) 8C Scan-rescan MRI on 
spinal cord. LA.1, LM.1, 
LM.4, LM.9 
(Hori et al., 
2018) 
DWI1 
(NODDI)  
MPM with 
multi-echo 
SPGR 
(MTsat) 
24P Clinical study: G-ratio 
maps of the spinal cord in 
Cervical Spondylotic 
Myelopathy. LA.3, LA.4, 
LM.2 , LM.9 
(Jung et 
al., 2018) 
DWI2 
(NODDI) 
Multi-echo 
SPGR 
(MET2*) 
5C; 15M* Two calibration methods 
for estimating MVF from 
myelin-water fraction. 
LA.3, LA.4, LM.1, LM.6, 
LM.8 
(Mancini et 
al., 2018) 
DWI2.4 (1), 
DWI2.9 (2) 
(NODDI) 
bSSFP (1), 
SPGR (2) 
(qMT) 
16C,15C Same as in Cercignani et 
al., 2017. Two datasets, 
dataset one acquired at 
1.5T (1) and dataset two 
(2) at 3T, each on a 
different imaging site. G-
ratio used to introduce 
axonal myelination in 
connectomics. B1+ 
correction was not 
reported for site (1). LA.3, 
LA.4, LM.1, LM.9 
(West et 
al., 2018a) 
DWI6 
(NODDI, 
WMTI, 
mcSMT) 
3D MSE 
(MET2) 
15M Electron microscopy and 
ex vivo MRI of mice 
models with varying 
degree of myelination 
using multi-shell diffusion 
MRI and 3D spin echo 
sequence. LA.3, LA.4, 
LA.5, LM.1, LM.6, LM.8 
(Kamagata 
et al., 
2019) 
DWI2 
(NODDI) 
MPM with 
multi-echo 
SPGR 
(MTsat) 
14C;14P The brain network 
topology was assessed 
using g-ratio as a marker 
for the connectivity 
strength, comparison 
between healthy controls 
and multiple sclerosis 
patients. LA.3, LA.4, 
LM.1, LM.2, LM.9  
(Yu et al., 
2019) 
DWI17.8 
(3CM) 
SPGR (MTV) 19C; 30P g-ratio and axon 
diameter mapping in 
patients with multiple 
sclerosis and healthy 
controls. LA.6, , LM.4, 
LM.9 
(Berman et 
al., 2019) 
DWI1 (DTI)  SPGR (MTV) 37C Estimating conduction 
velocities in fibre 
pathways using g-ratio 
and tractography. Data: 
37 subjects (20 younger 
and 17 older humans). 
LM.1, LM.4,LM.9 
(Drakesmit
h et al., 
2019) 
DWI6 
(CHARMED) 
SPGR & 
SSFP 
(mcDESPOT) 
21C Estimating conduction 
velocities in the corpus 
callosum using g-ratio 
and axon diameters. 
LA.6, LM.3,LM.9 
TABLE 1: Summary of in vivo MR g-ratio mapping studies. Limitations associated with 
the biomarkers for MVF (LM) and AVF/FVF (LA) are summarized in Table A1.  
C = health human controls; I = infants; M = mice; Mc = macaque; P = human patients; 
PI = preterm infants;  3CM = ActiveAx-like model (Alexander et al., 2010); * The mice 
data from (West et al., 2018a) were used.  
  
2 Methodology 
Biological tissue is formed of multiple microenvironments, which we refer to as 
compartments or pools. From an MRI perspective, key compartments in an imaging voxel 
comprised of human brain tissue, are those formed of aqueous and non-aqueous protons 
(Fig. 1a). The aqueous protons (𝑓𝑊) appear in a variety of microenvironments including 
water trapped within the myelin sheaths of fibre pathways (𝑓𝑀𝑊), or contained within the 
intra- (𝑓𝐴𝑊) and extra-cellular spaces (𝑓𝐸𝑊), and cerebrospinal fluid (𝑓𝐶𝑆𝐹). The non-
aqueous protons are bound to macromolecules (𝑓𝐵), including myelin (𝑓𝐵𝑀) and other 
macromolecules such as proteins (𝑓𝐵𝑁𝑀). We express these compartments as fractions 
of the imaging voxel under the simplifying assumption that, while the relative contribution 
will spatially vary, every voxel is fully described by its content of water and bound protons, 
i.e. 𝑓𝑊+ 𝑓𝐵 = 1. Of these tissue compartments, it is the axonal and myelin-associated 
compartments that are important in the context of in vivo g-ratio mapping (section 2.1).  
With MRI we tailor our experiments to maximise our sensitivity to specific compartments 
with the aim of quantifying the MVF and AVF respectively. To date, g-ratio mapping 
studies have either used relaxometry (Fig. 1b) or magnetisation transfer (Fig. 1c) 
techniques to quantify the myelin compartment (section 2.2), while diffusion imaging has 
been used to quantify the axonal compartment (Fig. 1d and section 2.3). These different 
imaging modalities have each evolved specific nomenclature over the course of their 
development. In this review, we aim, wherever possible, to unify these disparate notations 
using the fractional contributions outlined above and illustrated in figure 1. 
 
 Figure 1: Unified model of myelin and diffusion imaging.  To facilitate modelling, brain tissue is 
decomposed into four distinct tissue compartments (and CSF) that are of key relevance from an 
MRI perspective. These cover two broad categories: non-aqueous macromolecule-bound protons 
(fB) and aqueous (fW) protons, each of which may (fMW, fBM) or may not (fAW, fEW, fCSF, fBNM) be 
associated with myelin (a).  Myelin water imaging specifically focuses on characterising the 
distinct water micro-environments to quantify the myelin water fraction, MWF, i.e. the fractional 
contribution from myelin-associated water, fMW, relative to all water (b). Magnetisation transfer 
approaches focus instead on distinct macromolecular-bound and free water compartments, which 
can exchange magnetisation to quantify the bound pool fraction (BPF), i.e. the fractional 
contribution from the macromolecular environment (BPF=fB/(fB+fW), c). The diffusion weighted 
signal is sensitive to intra-axonal and extra-axonal water compartments, and potentially to an 
isotropic diffusion compartment such as CSF. By decomposing the signal, the intra-axonal water 
fraction (AWF) can be isolated: i.e. AWF = fAW/(fAW+fEW+fCSF). 
 
 
2.1 The Aggregate g-ratio Model 
Assuming a circular cross-section of axons, the microscopic 𝑔-ratio of an individual axon 
indexed by 𝑗 is defined as 𝑔𝑗 =
𝑅𝐼
𝑅𝑂
, where 𝑅𝐼  and 𝑅𝑂 are the inner and outer radii of the 
fibre respectively (see Fig. 2a). All further considerations are targeting the white matter 
(WM), which is considered to be composed of three discrete, non-overlapping 
compartments: axonal (A), myelin (M), and extracellular (E).  In this case, any sample 
volume of WM can be described by the volume fractions (VF) of each compartment, which 
sum up to one, i.e.: 𝐴𝑉𝐹 + 𝑀𝑉𝐹 + 𝐸𝑉𝐹 = 1. Using this WM model, Stikov and colleagues 
(Stikov et al., 2011, 2015) suggested that the aggregated 𝑔-ratio in an MRI volume (Fig. 
2b) can also be defined in terms of volume fractions as: 
(1) 𝑔𝑀𝑅𝐼 = √1 −
𝑀𝑉𝐹
𝑀𝑉𝐹+𝐴𝑉𝐹
 
To derive the relationship in Eq. (1) (see also (Stikov et al., 2011, 2015)), the 𝑔-ratio in 
an MRI voxel is assumed to be constant (Fig. 2c), whereas there is no restriction on the 
orientation of the axons in the voxel (Fig. 2d). Shortly after the g-ratio model was 
introduced, (West et al., 2016) suggested that 𝑔𝑀𝑅𝐼 is in fact capturing the fibre-area-
weighted mean (Fig. 2e) of all the microscopic g-ratios in the voxel (Fig. 2f). If the 
assumptions of Eq. (1) hold, this model can also be used with other imaging modalities 
(e.g., electron microscopy, where the 𝑀𝑉𝐹 and 𝐴𝑉𝐹 have been measured after 
segmentation of the image (West et al., 2016)). This efficient process allows the 
microscopic information obtained by these other modalities to be summarised over a 
spatial scale comparable to an MRI voxel, and therefore to be compared directly with the 
MR-based g-ratio in validation studies.  The aggregate g-ratio model has been developed 
specifically for white matter (Stikov et al., 2011, 2015; Campbell et al., 2018), where 
biomarkers of the MVF and AVF can be measured with MRI. In the following sections we 
will first outline the methods that have been used to date to quantify MVF and AVF in the 
context of g-ratio mapping.  
 
 
 
Figure 2: Schematic summary of the aggregated g-ratio model and its relation to the microscopic 
g-ratios. Myelinated axons (a) are represented by annual cylinders with myelin (blue) and axonal 
(yellow) compartments (b-f), other microstructural compartments are agglomerated in the 
background (grey). The aggregated g-ratio (𝑔𝑀𝑅𝐼) can be formulated as a function of the axonal 
and myelin volume fractions (𝐴𝑉𝐹 and 𝑀𝑉𝐹 respectively, b). In this model, all axons within a voxel 
are assumed to have the same g-ratio. In the initial model suggested by Stikov et al. in 2011, the 
axons were also assumed to be orientated in parallel (c). This assumption was subsequently 
relaxed (Stikov et al., 2015), allowing arbitrary axonal orientation (d). West et al. (2016) showed 
that the aggregated g-ratio is related to the fibre area-weighted mean of the microscopic g-ratios 
(f) – in the figure the weights are represented by the degree of transparency to indicate the 
weighting towards larger fibres (e).  
2.2 Myelin Volume Fraction 
A variety of different MRI-based measures have been used to characterise the myelin 
content within a voxel (Alonso‐ Ortiz et al., 2015; MacKay and Laule, 2016; Sled, 2018). 
Here we focus on myelin-water imaging (MWI) and magnetization transfer (MT) imaging.   
In both cases, each of which will be discussed in turn, the measure aims to be reflective 
of the fractional myelin content within the imaging volume, i.e. the MVF. This is done by 
quantifying either the myelin water fraction (𝑀𝑊𝐹 =
𝑓𝑀𝑊
𝑓𝑊
, Fig. 1b) or the bound pool 
fraction (𝐵𝑃𝐹 =
𝑓𝐵
𝑓𝑊+𝑓𝐵
, Fig. 1c).  In either case, an additional calibration step is clearly 
required to convert the measure to the MVF (
𝑓𝑀𝑊+𝑓𝐵𝑀
𝑓𝑊+𝑓𝐵
) in order to accurately compute the 
g-ratio (West et al., 2018b).  As noted by Campbell et al. (Campbell et al., 2018) this 
calibration step is crucial to the accuracy and precision of g-ratio mapping and will be 
discussed in detail in section 3. 
 
2.2.1 MWF based on Myelin Water Imaging 
Starting from Figure 1, the simplest water imaging model quantifies the density of free 
water protons within an imaging voxel, i.e. the proton density (PD) (Tofts, 2004).  Under 
an assumption of complete longitudinal recovery within each repetition time, TR, the 
extrapolated MR signal at an echo time, TE, of 0ms (𝑆0) is proportional to the product of 
the fractional water content, 𝑓𝑊, a calibration factor, 𝐶, that accounts for the concentration 
of protons in the voxel relative to that of free water, and the spatially-varying receive field 
sensitivity, 𝑅, : 𝑆0 = 𝑅 𝐶 𝑓𝑊 such that 𝑓𝑊 + 𝑓𝐵 = 1 (Fig. 1c). The receive field modulation 
must be estimated and removed (𝑆0
′ = 𝐶 𝑓𝑊, see section 2.2.3) prior to final calibration, 
which is done with respect to a reference, e.g. cerebrospinal fluid, CSF: 𝑃𝐷 =
𝑆0
′
𝑆0,𝐶𝑆𝐹
′ = 𝑓𝑊. 
This is equivalent to assuming that the volume fraction of macromolecules is zero (𝑓𝐵 ≈ 0 
and 𝑓𝑊 = 1), i.e. 𝑆0,𝐶𝑆𝐹
′ = 𝐶. The remaining contents of the voxel have recently been 
referred to as the macromolecular tissue volume (𝑀𝑇𝑉 = 1 − 𝑃𝐷 = 𝑓𝐵) (Mezer et al., 
2013). PD mapping typically makes no distinction between different water 
microenvironments (e.g. myelin water v’s non-myelin water) and instead estimates the 
sum of contributions from all compartments (Fig. 1b,c) under the assumption of a mono-
exponential signal decay. Therefore, MTV might vary with the minimum echo time, as well 
the echo spacing, at which the signal was sampled (more details can be found in (Tofts, 
2004)).  
By contrast, myelin water imaging (MWI, (Alonso‐ Ortiz et al., 2015)) extends this model 
to encompass multiple distinct water compartments, each with specific relaxation 
behaviour contingent on the local microenvironment.  MWI quantifies myelin-associated 
aqueous protons in a voxel as a fraction of the total MR visible water signal, i.e. 𝑀𝑊𝐹 =
𝑓𝑀𝑊
𝑓𝑊
  as defined in Figure 2b. To date, three main approaches to myelin water imaging 
have been used for g-ratio mapping using MRI. Each technique exploits a different 
relaxation property to stratify the different tissue water compartments (MacKay and Laule, 
2016): (1) multi-echo spin echo imaging to quantify compartment-specific transverse 
relaxation times (Melbourne et al., 2016; West et al., 2018a), T2, (2) multi-echo gradient 
echo imaging to quantify compartment-specific effective transverse relaxation times 
(Jung et al., 2018) , T2*, and (3) multi-compartment driven equilibrium single pulse 
observation of T1 and T2 (mcDESPOT, (Deoni et al., 2008; Dean et al., 2016; Drakesmith 
et al., 2019)) to distinguish fast and slow relaxing compartments based on their distinct 
T1 and T2 relaxation and exchange behaviour. 
In MWI, the MWF is most commonly estimated by characterising the proportion of the 
water signal originating from different microstructural environments based on their distinct 
transverse relaxation times (T2). To do this, it is assumed that the residency time, , of 
the protons in each water pool is sufficiently long that their distinct relaxation behaviour 
can be discerned.  The case  >> T2 indicates a slow exchange regime, which can 
equivalently be described by an exchange rate, k = 1/ << 1/T2.  In this case, multi-
exponential behaviour, with a component originating from each of the water pools having 
distinct amplitude and relaxation times, can be discerned (Zimmerman and Brittin, 1957).  
Indeed, T2 distributions from normal brain have been shown to contain multiple peaks 
that can be attributed to myelin water trapped between the lipid bilayers, intra/extracellular 
water and cerebral spinal fluid (Whittall et al., 1997; MacKay and Laule, 2016). 
To quantify distinct T2 times, data are typically acquired using a multi-echo spin echo 
readout with a range of echo times. Each voxel is assumed to contain contributions from 
an unspecified number of slow or non-exchanging environments, each with distinct T2 
decay times. Fitting the data to this model is typically done with a regularised non-
negative least squares approach (Whittall and MacKay, 1989; MacKay et al., 2006), in 
which the regularisation ensures smoothly varying signal amplitudes as a function of T2.  
After fitting, the myelin compartment is assigned to the short T2 peaks, requiring a 
threshold T2 time to be specified.  The MWF is then estimated as the area under the 
peaks below this threshold T2 time relative to the area under all peaks, i.e. 
𝑓𝑀𝑊
𝑓𝑊
 (MacKay 
et al., 2006).  This ignores any differential weighting that might be present, for example 
due to compartment-specific T1 times. In white matter, at least two different T2 relaxation 
times have been reported, which are associated with different tissue compartments 
(MacKay et al., 2006; Cercignani et al., 2018): (1) myelin water having a T2 of about 15 – 
30 ms, and (2) water in the intra- and extra cellular spaces with a T2 of about 80 – 90 ms, 
at 3T. It should also be noted that the T2 relaxation times of the intra- and extra cellular 
spaces likely differ (Dortch et al., 2013; Veraart et al., 2018; McKinnon and Jensen, 2019) 
and that there is exchange between these compartments that also influences the T2 
distribution in white matter (Sled et al., 2004). These effects will be revisited in section 
3.1.1 but have also been discussed in detail elsewhere (Does, 2018).  
A similar approach uses a multi-echo gradient echo acquisition in lieu of acquiring spin 
echoes.  In this case compartment-specific T2* times are estimated instead of T2 (Lenz et 
al., 2012; Sati et al., 2013).  This approach is more time efficient, less vulnerable to 
transmit field inhomogeneity and less demanding from an RF power perspective since 
refocusing pulses are not required. However, given that the signal is governed by the 
more rapid T2* decay, it does suffer from reduced signal-to-noise ratio (SNR) relative to 
spin echo approaches. Fitting complex-valued data to the multi-exponential decay model 
has been shown to increase the robustness of MWF estimates made with this approach 
(Nam et al., 2015b).   
Rather than modelling distinct tissue compartments solely from the decay of the 
transverse magnetisation, the mcDESPOT approach integrates spoiled gradient echo 
(SPGR) and balanced steady-state free precision (bSSFP) images, acquired with 
different nominal flip angles, to fit a two compartment model of the steady state signal 
(Deoni et al., 2008). The combination of these two acquisition types allows both T1 
(SPGR) and T2 (bSSFP) to be estimated (Deoni et al., 2013). In the mcDESPOT model 
distinct relaxation times are determined for a fast and a slow relaxing pool, as well as the 
exchange rate (k), or residency time () of the two pools in the condition of chemical 
equilibrium. The fast relaxing pool is subsequently assumed to be myelin-associated 
water allowing the MWF to be quantified. The relaxation and exchange of these two pools 
is modelled using the Bloch-McConnell equations, which allows analytical solutions for 
the steady state signal to be derived (McConnell, 1958; Liu et al., 2016).  Fitting the 
acquired data to these signal models requires seven distinct model parameters to be 
estimated: T1, T2 and fractional amplitude for each compartment as well as the exchange 
between them. 
 
2.2.2 BPF based on Magnetisation Transfer 
Like PD mapping, magnetisation transfer (MT) based approaches simplify the 
characterisation of white matter to two distinct pools (Fig. 1c). In this case one is 
comprised of an aqueous environment and the other a non-aqueous environment that, in 
the context of g-ratio mapping, is assumed to be associated with myelin. Unlike “free” 
water, such as found within the intra- or extra-cellular compartments, that has a sharp 
resonance linewidth, the “bound” non-aqueous protons have a much more 
heterogeneous microenvironment leading to a much broader range of MR frequencies 
and by consequence a very short T2 in the range of tens of microseconds, meaning that 
the transverse magnetisation component is undetectable with MRI, unless ultra-short TE 
approaches are adopted (Sheth et al., 2016; Jang et al., 2020; Weiger et al., 2020).  
However, given its broad range of resonant frequencies, this bound pool can be 
selectively saturated through the application of an off-resonance radiofrequency pulse 
prior to conventional excitation and signal detection. This pre-pulse can selectively 
saturate the longitudinal magnetisation of the bound pool while leaving the free pool 
largely unaffected.  Subsequently, the process of magnetisation transfer (MT), primarily 
occurring through dipolar coupling between the bound and free pools, leads to an 
observable reduction in the measured signal intensity (Wolff and Balaban, 1989; Sled and 
Pike, 2001; Sled, 2018; van Zijl et al., 2018). MT techniques capture the relative 
proportion of magnetisation in the bound pool relative to the free pool through the pool 
size ratio (𝑃𝑆𝑅 =
𝑓𝐵
𝑓𝑊
 (Sled and Pike, 2001) and Fig. 1c).  Analogously to the MWF in MWI, 
the BPF, is defined as the magnetisation fraction within the bound pool relative to the total 
magnetisation in both pools (Sled, 2018): 𝐵𝑃𝐹 =
𝑓𝐵
𝑓𝑊+𝑓𝐵
 in Fig. 1c .  In the first g-ratio 
mapping studies, the measured BPF was calibrated against histological data to convert it 
to an estimate of the MVF and combined with a diffusion-based measure of the FVF to 
estimate the g-ratio (Stikov et al., 2011, 2015). 
The simplest means of probing the macromolecular bound pool via MT is to acquire an 
image using a pre-pulse with a single off-resonance frequency interleaved with a standard 
excitation pulse. The magnetisation transfer ratio (MTR) is defined as the normalised 
signal decrease relative to a reference image with only the standard excitation pulses 
(Henkelman et al., 2001).  While this measure has been shown to be reflective of myelin 
content via histological analysis (Schmierer et al., 2004) hardware dependencies remain 
and reduce its comparability across individuals (Callaghan et al., 2015).  A more robust 
measure that incorporates correction for both spatially varying T1 and B1+ effects is the 
magnetisation transfer saturation (MTsat). This measure quantifies the percentage 
saturation per TR of the steady state SPGR signal that would result from a dual excitation 
sequence, and is dependent on the BPF (Helms et al., 2008).  MTsat has been shown to 
be more robust to B1+ inhomogeneity than MTR (Callaghan et al., 2015) and to empirically 
correlate with the pool size ratio, F (Campbell et al., 2018). 
More comprehensive modelling of the two magnetisation pools is obtained through 
quantitative MT (qMT) imaging.  This approach aims to separate the contributions of the 
free and bound pools by explicitly modelling the distinct T1 and T2 relaxation times of the 
pools and incorporating the exchange between them, under the assumption of chemical 
equilibrium.  The absorption lineshape of the bound pool must also be modelled, and is 
often assumed to be super-Lorentzian, with a T2 in the region of tens of microseconds 
(Morrison and Henkelman, 1995).  With this approach, the BPF can be estimated from 
the fractional magnetisation contributions of the two pools.  To estimate this extended set 
of parameters, multiple images, sampling the so called z-spectrum, are acquired, each 
using a pre-pulse with a different off-resonance frequency (Sled and Pike, 2001; Cabana 
et al., 2015; Sled, 2018). 
An intriguing, but not yet validated, approach that has also been used in the context of g-
ratio mapping is to use multi-compartment Bloch simulations to model the myelin volume 
fraction within the voxel directly (Warntjes et al., 2016; Hagiwara et al., 2017). 
 
2.2.3 Protocol Considerations for MVF mapping 
A range of different protocols can be used to estimate the proton density, and by 
consequence the macromolecular tissue volume (Warntjes et al., 2007; Volz et al., 2012; 
Baudrexel et al., 2016; Mezer et al., 2016; Wang et al., 2018; Callaghan et al., 2019; Lorio 
et al., 2019).  This approach requires an estimate of the receiver field sensitivity, 𝑅, which 
can be obtained by constrained model fitting or measurement (Mezer et al., 2016).  The 
normalisation step to express PD as a fraction, or more commonly a percentage, of the 
concentration of protons in pure water requires a reference region to be defined, e.g. 
within the CSF-filled ventricles.  However, the optimal choice of the normalisation region 
will depend on the acquisition scheme since sufficient SNR is required for robust 
estimation (CSF was used in (Berman et al., 2018) and white matter in (Ellerbrock and 
Mohammadi, 2018a)). The accuracy and precision of the PD estimation will in turn dictate 
the accuracy and precision of the MTV estimate.  The mapping of PD was introduced in 
the context of fully relaxed signal (i.e. TR >> T1). However, for reasonable scan times, 
this requirement can be relaxed, but in this case it is necessary to correct for spatially 
varying T1 recovery.  
Multi-compartment MWI necessitates short echo times to adequately sample the decay 
of the short T2 myelin-associated water compartment (Whittall et al., 1999). This extends 
the minimum achievable TR and can lead to long acquisition times, particularly for spin 
echo based approaches, unless spatial coverage or resolution are sacrificed.  Acquiring 
multiple spin echoes in a single readout increases temporal efficiency, but the train of 
pulses can lead to the refocusing of echoes from unwanted pathways, i.e. the production 
of stimulated echoes, when the transmit field, B1+, is inhomogeneous.  Correction 
schemes based on simulating the impact of these echoes (e.g. (Lebel and Wilman, 2010)) 
have been proposed and can be incorporated into the fitting procedure. 2D slice-selective 
approaches are also vulnerable to distorted slice profile effects, which can be mitigated 
either by modifying the sequence to ensure a sufficiently broad refocusing width, or by 
accounting for the effect during processing (Lebel and Wilman, 2010; Nöth et al., 2017). 
The large number of refocusing pulses also increases the specific absorption rate (SAR) 
of the sequence and can be a limiting factor at higher field strengths.  
MTR and MTsat are time efficient means of quantifying the effect of magnetisation 
transfer. As highlighted earlier, MTsat is more hardware robust. In addition, high 
resolution maps can be obtained with whole brain coverage in reasonable scan times 
making it particularly appealing for clinical studies. This efficient method was used in the 
first group study mapping the g-ratio in vivo (Mohammadi et al., 2015). However, a 
limitation of these rapid approaches is that they are semi-quantitative.  The saturation of 
the bound pool, and therefore of the free pool via magnetisation transfer, will depend on 
the particular off-resonance pulse used, most notably the power and offset frequency. For 
further details, acquisition protocols and software for estimating this parameter see e.g. 
(Tabelow et al., 2019). 
qMT approaches circumvent this limitation by quantifying specific physical parameters. 
However, the extended datasets required to fit the full qMT model fitting lead to a trade 
off between scanning durations and spatial resolution and/or coverage.  To constrain the 
model fits, parameters can be fixed, e.g. the T1 of the free and bound pool can be set 
equal to each other, or an “observed” T1 can be separately measured and integrated into 
the fitting to relate the T1 times of the bound and free pools.  For further details and 
software available for fitting such models, see e.g. (Cabana et al., 2015).  
Clearly brain tissue can be characterised by a very broad range of physical parameters.  
The multi-parameter mapping (MPM) quantitative MRI protocol offers a comprehensive 
approach providing high resolution, whole brain estimates of (single compartment) T1, 
T2*, PD, MTV and MTsat, with correction for transmit and receive field effects, in clinically 
feasible scan times (Weiskopf et al., 2013; Callaghan et al., 2019; Tabelow et al., 2019).  
As such it provides simple proxies for both the macromolecular (via MTsat & MTV) and 
free water pools (PD) in a single protocol. 
 
2.3 Axonal Volume Fraction and Fibre Volume Fraction 
Diffusion MRI is the method of choice to separate the intra- and extra-axonal tissue 
compartments (𝑓𝐴𝑊 and 𝑓𝐸𝑊, Fig. 1d) because of the distinct diffusion properties of water 
in these compartments. However, as detailed above, the myelin-associated water 
compartment has a short T2.  This means that diffusion-weighted MRI is insensitive to 
myelin water because of the comparatively long minimum echo time required to 
accommodate the application of diffusion gradients. Nonetheless, there are several 
different diffusion-based approaches available to probe the intra-axonal tissue 
compartment. Detailing each of these goes beyond the scope of g-ratio mapping. For 
those interested in more details, we refer to other excellent reviews (e.g. (Alexander et 
al., 2019; Novikov et al., 2019)). Here we will specifically focus on those approaches that 
have been used to date to estimate the intra-axonal volume fraction for the purpose of 
computing the aggregated g-ratio. These studies can be subdivided into two categories: 
the studies that have used standard DTI data and those that have used multi-shell (and 
even more advanced) diffusion MRI protocols. Each category will be discussed in turn.  
 
2.3.1 FVF from DTI data 
The first category of studies requires only a limited set of measurement parameters, 
including only a single b-value and a modest number of diffusion directions, as defined 
by the DTI protocol. Therefore, these studies refrain from explicitly modelling more than 
one tissue compartment. A feature of these studies was the interpretation of diffusion-
MRI based measurements of the axonal compartment as the FVF rather than the AVF, 
which, given the insensitivity of diffusion MRI to myelin water, is probably incorrect as we 
will discuss further in the next section.  
DTI: The first g-ratio mapping study by Stikov et al. (Stikov et al., 2011) used simulations, 
in which axons were modelled as straight, parallel cylinders to establish a second order 
relationship between the fractional anisotropy (FA) of the diffusion tensor and the total 
𝐹𝑉𝐹. The assumption of straight and parallel cylinders, however, restricted the application 
of this model to white matter regions with well aligned fibres. As a result, it has only been 
applied to the corpus callosum to date (Stikov et al., 2011; Berman et al., 2018).  
TFD: The diffusion model used by Mohammadi et al. (Mohammadi et al., 2015) for g-ratio 
mapping was based on the tract-fibre density (TFD), which is not restricted to well-aligned 
fibre pathways and thus could be applied across the whole brain. The TFD was derived 
from fibre orientation distributions (Reisert et al., 2013) and assumed to be directly 
proportional to the 𝐹𝑉𝐹. The proportionality constant that related TFD to 𝐹𝑉𝐹 was 
combined with the calibration coefficient that related the MTsat myelin marker used to 
capture 𝑀𝑉𝐹.  The resulting calibration constant was estimated by referencing against a 
ground truth g-ratio value from literature (Mohammadi et al., 2015). This calibration 
approach will be further discussed in the context of myelin biomarkers in section 3.2. 
However, Ellerbrock et al. (Ellerbrock and Mohammadi, 2018a) recently showed the TFD-
based 𝐹𝑉𝐹 parameter to be less stable in terms of repeatability and comparability than 
𝐹𝑉𝐹 estimates derived from the Neurite and Orientation Dispersion in Diffusion Imaging 
(aka NODDI) model (Zhang et al., 2012), discussed in more detail in the next section. 
 
2.3.2 AVF from multi-shell diffusion MRI data 
Using a more extensive set of experimental measurement parameters, i.e. multiple b-
values  (aka diffusion shells), allows the second category of studies to use a more 
principled model for the diffusion signal, the so-called “standard model” (Novikov et al., 
2019).  The standard model is built upon well-established signal models for two tissue 
compartments (for a summary see, e.g., (Novikov et al., 2019)), the axonal (𝐴) and extra-
cellular (𝐸) compartments (Fig. 3a.ii). A restricted signal component is assumed to come 
from the axonal compartment, which is modelled as impermeable sticks (Fig. 3a.iii). A 
hindered signal component describes the extra-cellular space, which is modelled using a 
3D anisotropic diffusion tensor. Such an example is depicted in Figure 3c for the White 
Matter Tissue Integrity (WMTI) model, showing the axially-symmetric ellipsoidal tensor 
composed of axial (𝐷𝐸,||) and perpendicular (𝐷𝐸,⊥) extra-cellular diffusivities.  
In contrast to g-ratio studies based on DTI data, those using multi-shell diffusion MRI data 
also acknowledge the fact that the direct contribution of myelin water in the diffusion MRI 
signal is negligible (Fig. 3a.ii). As a consequence, their models take into account that the 
axonal compartment estimated from the visible MRI signal in a typical diffusion 
experiment is not 𝐴𝑉𝐹 =
𝐴𝑉𝐹
𝑀𝑉𝐹+𝐴𝑉𝐹+𝐸𝑉𝐹
 (Fig. 3a.i) but rather the axon water fraction (𝐴𝑊𝐹), 
i.e. intra-axonal signal divided by the signal from the extra- and intra-cellular space: 
𝐴𝑊𝐹 =
𝑓𝐴𝑊
𝑓𝐴𝑊+𝑓𝐸𝑊
 (Fig. 1d) and thus 𝐴𝑊𝐹 =
𝐴𝑉𝐹
𝐴𝑉𝐹+𝐸𝑉𝐹
 (Fig. 3a.ii). These studies follow the 
suggestion of  Stikov et al. (Stikov et al., 2015) to estimate 𝐴𝑉𝐹 by rescaling the 𝐴𝑊𝐹 
accounting for the unsampled 𝑀𝑉𝐹, i.e.: 
(2) 𝐴𝑉𝐹 = (1 − 𝑀𝑉𝐹) 𝐴𝑊𝐹.  
 
 
Figure 3: Depicted are the compartments of the g-ratio white matter (WM) tissue model as seen 
by diffusion MRI (a). An axial view of the human brain (b) is used to indicate WM regions where 
two example signal models that have been used to estimate the axonal water fraction (𝐴𝑊𝐹) are 
applicable (c,d). (a.i): The cross-section of a representative myelinated axon and the associated 
tissue compartments in the g-ratio model: axonal (𝐴𝑉𝐹 in yellow), myelin (𝑀𝑉𝐹 in blue), and extra-
cellular (𝐸 in gray) volume fractions (𝑉𝐹). (a.ii): Only two out of three compartments of (a.i) 
contribute to the diffusion signal: 𝑆𝐸 and 𝑆𝐴. The contribution from myelin is negligible because of 
its short T2, i.e. 𝑆𝑀 = 0. (a.iii): Typical diffusion models assume that the axonal compartment is 
composed of a population of sticks (depicted lengthwise in yellow) in which there is measureable 
diffusivity only along the length of the sticks (i.e. 𝐷𝐴,|| > 0 and 𝐷𝐴,⊥ ≈ 0). (c): The White Matter 
Tissue Integrity (WMTI) model is comprised of distinct signal contributions from within axons (𝑆𝐴) 
and from the extra-cellular space (𝑆𝐸) with corresponding signal fractions: 𝜈 from 𝑆𝐴 and (1 − 𝜈) 
from 𝑆𝐸 and compartment-specific diffusivities: 𝐷𝐴,||, 𝐷𝐸,|| and 𝐷𝐸,⊥. However, WMTI can only be 
applied to WM regions with well-aligned fibre pathways because it assumes parallel sticks thereby 
excluding disperse orientations. To satisfy this model assumption it has been used only within the 
corpus callosum (see (b)). (d) The Neurite and Orientation Dispersion in Diffusion Imaging 
(NODDI) model is comprised of axonal (𝑆𝐴) extracellular (𝑆𝐸) and isotropic (𝑆𝑖𝑠𝑜) signal 
compartments and estimates signal fractions for each (i.e. 𝜈, (1 − 𝜈) and 𝜈0 respectively). To 
improve fitting stability, the NODDI model makes very strong assumptions, e.g.: the intra- (𝐷𝐴,||) 
and extra-axonal parallel diffusivities (𝐷𝐸,||) are assumed to be the same and are fixed, as is the 
diffusivity of the isotropic compartment (𝐷0) corresponding to CSF.  The parallel and perpendicular 
diffusivities are assumed to be related via the tortuosity model: 𝐷𝐸,⊥ = 𝐷𝐸,||(1 − 𝜈). The depicted 
values are for the in vivo case. However, NODDI does not assume parallel fibres, but rather 
accounts for fibre dispersion (𝜅), which is described by a Watson distribution (Stoyan, 1988).  
NODDI can therefore be used in regions with more disperse fibre orientations (as depicted in (b)).    
 
WMTI: The WMTI model (Fieremans et al., 2011) contains signal contributions from intra-
axonal (𝑆𝐴) and extra-cellular (𝑆𝐸) compartments and is therefore directly related to the 
“standard model” of diffusion MRI. In this model, the signal fraction of sticks (𝜈 =
𝑓𝐴𝑊
𝑓𝐴𝑊+𝑓𝐸𝑊
, 
Fig. 1d) is directly used as proxy for 𝐴𝑊𝐹 while 1 − 𝜈 (=
𝑓𝐸𝑊
𝑓𝐴𝑊+𝑓𝐸𝑊
, Fig. 1d) estimates the 
extra-cellular water fraction (Fig. 3c). In addition to 𝐴𝑊𝐹, WMTI simultaneously estimates 
the intra-axonal diffusivity (𝐷𝐴,||) and two extra-cellular diffusivities (𝐷𝐸,⊥ and 𝐷𝐸,||) of an 
axially-symmetric ellipsoidal tensor. However, it assumes parallel fibres and therefore has 
applied been only to the corpus callosum (West et al., 2018a).  
mcSMT: Like WMTI, the multi-compartment Spherical Mean Technique (mcSMT) model 
developed by Kaden et al. (Kaden et al., 2016) is based on the “standard model”. But, 
instead of assuming parallel fibres, it uses the SMT to factor out the contribution of fibre 
orientation. As a result, it can be applied to the whole brain. Similar to the WMTI model, 
mcSMT estimates the signal fraction of the intra-axonal space, 𝜈. This has been used as 
a proxy for the 𝐴𝑊𝐹 in g-ratio mapping (West et al., 2018a). In the mcSMT model, the 
intra- and extra-cellular parallel diffusivities are assumed to be equal (𝐷𝐴,|| = 𝐷𝐸,||) and the 
tortuosity model (Szafer et al., 1995) is used to relate the extra-cellular parallel and 
perpendicular diffusivities to each other via 𝜈: 𝐷𝐸,⊥ = (1 − 𝜈)𝐷𝐸,||.  
NODDI: The most commonly used method to estimate the 𝐴𝑊𝐹 in g-ratio mapping has 
been the NODDI model (Fig. 3d, (Zhang et al., 2012; Stikov et al., 2015)). As compared 
to the aforementioned models, NODDI is a 3-compartment signal model. It not only 
models the two signal compartments from the intra-axonal and extra-cellular space but 
also a third isotropic signal component (𝑆𝑖𝑠𝑜with an associated signal fraction ν0 =
𝑓𝐶𝑆𝐹
𝑓𝐴𝑊+𝑓𝐸𝑊+𝑓𝐶𝑆𝐹
, Fig. 1d) to account for any partial-volume contamination by freely diffusing 
water, e.g., as in CSF. To compensate for the increased number of model parameters 
and stabilize model fitting, the diffusion constants are fixed (Fig. 3b). To this end, as in 
the mcSMT model, the tortuosity model is used to relate the extra-axonal diffusivities via 
𝜈: (𝐷𝐸,|| = (1 − 𝜈)𝐷𝐸,⊥). Moreover, the intra-axonal and extra-axonal parallel diffusivities 
are assumed to be equal (𝐷𝐴,|| = 𝐷𝐸,||) and have a predefined value, as does the diffusivity 
of the isotropic compartment (𝐷0). To account for the 3-compartment nature of NODDI, 
Stikov et al. (2015) suggested the following relation between the NODDI signal fractions 
(Fig. 3d) and the 𝐴𝑊𝐹: 𝐴𝑊𝐹 = 𝜈(1 − 𝜈0). By scaling 𝜈 with 1 − 𝜈0, (𝜈(1 − 𝜈0) =
𝑓𝐴𝑊
𝑓𝐴𝑊+𝑓𝐸𝑊
(1 −
𝑓𝐶𝑆𝐹
𝑓𝐴𝑊+𝑓𝐸𝑊+𝑓𝐶𝑆𝐹
) =
𝑓𝐴𝑊
𝑓𝐴𝑊+𝑓𝐸𝑊+𝑓𝐶𝑆𝐹
) such that the intra-axonal signal fraction is 
corrected for the contribution of the CSF compartment, to ensure the g-ratio WM model 
assumption, i.e. 𝐴𝑉𝐹 + 𝑀𝑉𝐹 + 𝐸𝑉𝐹 = 1 (Fig. 1d). 
NODDI accounts for fibre dispersion using the single-parameter Watson distribution 
(Stoyan, 1988; Jespersen et al., 2012), making it applicable for whole brain g-ratio 
mapping.  
CHARMED: Compared to other diffusion models that have been used for g-ratio mapping, 
the Combined Hindered and Restricted Models of water diffusion (CHARMED) approach 
makes the fewest assumptions. It models diffusion in the extra-cellular space by a full 
ellipsoidal tensor (whereas the NODDI and WMTI models assume an axially-symmetric 
ellipsoid), and, in principle, it can account for crossing fibre configurations (Assaf et al., 
2004; Assaf and Basser, 2005) unlike the standard NODDI approach. The CHARMED 
model can be further extended to additionally estimate axon diameters (e.g. (Assaf et al., 
2008; Alexander et al., 2010; Huang et al., 2016)). This has been used by Duval et al. for 
g-ratio mapping in the spinal cord (Duval et al., 2017) and by Yu et al. (Yu et al., 2019) in 
patients with multiple sclerosis. However, such a protocol requires more extensive (and 
time-consuming) data acquisition. 
 
2.3.3 Protocols for AVF mapping 
While the first category of studies requires only a standard single-shell DTI protocol 
(Stikov et al., 2011; Mohammadi et al., 2015; Berman et al., 2018), the minimum 
requirement protocol for the second category of studies depends on the model to be used 
for AWF mapping. The WMTI model parameters can be estimated from the diffusion 
kurtosis tensor measurement (Fieremans et al., 2011; Jespersen et al., 2018). The 
NODDI, mcSMT, and WMTI model parameters can be estimated from a two-shell 
diffusion MRI protocol composed of a “lower” (𝑏~1
𝑚𝑠
𝜇𝑚2
) and a “higher” diffusion weighting 
(𝑏~2
𝑚𝑠
𝜇𝑚2
) 1. In contrast to the aforementioned models, the CHARMED model typically 
requires a more extended diffusion MRI protocol: Drakesmith et al. used a five shell 
diffusion MRI dataset for g-ratio weighted imaging (Drakesmith et al., 2019). Extending 
the CHARMED model to also estimate axon diameters requires an even more advanced 
protocol where the b-values and additional diffusion parameters such as diffusion 
sensitization times also have to be changed ( see (Duval et al., 2017) for g-ratio mapping). 
Typical protocol-associated issues that can introduce biases are: ceiling effects (i.e. 𝜈 =
1 in white matter, which can be encountered with NODDI if b-shells are sub-optimally 
sampled (recommendations for optimal sampling provided in (Zhang et al., 2012)). Rician 
noise in low SNR data can also lead to bias in AWF estimation can propagate into the 
                                                          
1 Note that these parameters are for in vivo imaging and will be different for ex vivo MRI. For 
example, in the study by (West et al., 2018a) the low and higher diffusion weighting were at 
𝑏~3
𝑚𝑠
𝜇𝑚2
 and 𝑏~6
𝑚𝑠
𝜇𝑚2
, respectively. 
AWF parameters from WMTI.  Mapping accurate AWF parameters in the spinal cord 
comes with additional challenges because of increased susceptibility to nonlinear motion 
(e.g. due to swallowing, (Yiannakas et al., 2012)), physiological noise (e.g. (David et al., 
2017)), or partial volume effects due to its small size (1 cm in diameter). 
 
3 Challenges for aggregated g-ratio mapping 
The most important prerequisite of g-ratio mapping with MRI is that the biomarkers of 
MVF and AVF be accurate. Two key requirements for an accurate biomarker are model 
validity and a one-to-one correspondence between the MRI-biomarker and the gold 
standard MVF and AVF. While the first point can be investigated by theoretical evaluation 
of the model, the second point is typically not fulfilled necessitating a calibration step. 
Another important challenge is related to imaging artefacts and their impact on the multi-
modal combination of MVF and AVF biomarkers. In this section, we will first discuss the 
question of model validity associated with MRI-based MVF and AVF biomarkers, then we 
will use a simulation experiment based on ex vivo data to improve our understanding of 
the calibration step, and finally we discuss imaging artefacts associated with the multi-
modal combination of MRI data. 
 
3.1 Model Validity 
It is important to bear in mind that “all models are wrong but some are useful” 2.  In the 
following sections we will cover some of the key model assumptions made to facilitate in 
                                                          
2 The aphorism is generally attributed to the statistician George Box, although the underlying concept 
predates Box's writings (https://en.wikipedia.org/wiki/All_models_are_wrong). 
vivo mapping of the AVF and MVF and enable g-ratio mapping.  We will also discuss the 
consequent limitations of application.  
 
3.1.1 MVF models 
The simplest model for estimating 𝑓𝐵 is based on PD mapping, in which a mono-
exponential, i.e. single water compartment, is typically assumed when extrapolating the 
signal to a TE of 0ms to remove confounding T2(*) decay.  This is clearly not valid and 
constituent water compartments within a voxel will have variable influence depending on 
the echo times and spacings used (Whittall et al., 1999). This will be the case for both PD 
mapping and MWI. In general, longer apparent T2(*), and smaller fractional contribution 
from short T2 components, are observed as the first TE is increased (Cercignani et al., 
2018).  It is also important to fully sample the decay, which requires sufficiently long echo 
times to capture any slowly decaying compartments. However, when fitting magnitude 
data with long echo times, significant biases can be introduced by the Rician noise 
distribution and greatly alter the measured T2(*) values (Bjarnason et al., 2013).  As noted 
earlier, complex-valued fitting can be particularly beneficial when the MWF is 
characterised via the shorter T2* decay (Nam et al., 2015b) of gradient echo imaging. 
Moreover, it has recently been shown that MWF depends on the orientation of fibres with 
respect to the external magnetic field (Birkl et al., 2020). Sensitivity to B0 inhomogeneity 
can also bias model fits as can phase errors caused by physiological effects, such as 
breathing and eddy currents (Nam et al., 2015a) and motion, which distorts the decay 
(Magerkurth et al., 2011).  Vulnerability to physiology and motion, together with partial 
volume effects, are particularly problematic for spinal cord imaging (Duval et al., 2017, 
2018; Hori et al., 2018).  More generally, these potential sources of artefact can manifest 
differently in vivo and ex vivo, meaning that while some techniques may work well in post 
mortem data, e.g. achieving cross-validation with histological data, they may not 
necessarily work well in vivo. 
Models assuming two pools, either distinct non-exchanging water pools in myelin water 
imaging (Fig. 1b) or a bound and free pool that interact via magnetisation transfer (Fig. 
1c) are also limited by the fact that they do not describe the full complexity of the tissue’s 
microstructure. Higher numbers of pools, are undoubtedly present (c.f. even the simplified 
model of Fig. 1a) but are unlikely to be distinguishable based on distinctly observable 
relaxation behaviour either because of exchange or because it would require unattainable 
measurement precision.  Simulation studies of more complete models have helped us to 
better understand the limitations of these simplifications. 
In MWI, a slow exchange rate, is central to the possibility of differentiating water pools, 
and their fractional sizes, based on experimentally distinguishable T2 times. As the 
exchange rate increases to a more intermediate regime, distinct compartments may still 
be discernible, but the relaxation times will appear reduced, as will the MWF (Does, 
2018).  The situation is further complicated by the presence of noise, which, even at low 
levels, can further broaden the distribution of apparent relaxation times, and even lead to 
distinct water environments merging in the three pool case (Does, 2018). The rate of 
magnetisation transfer exchange between macromolecular and water pools is an order 
of magnitude larger than the diffusion-driven exchange rate between water compartments 
(c.f. non-directional exchange rates of 10s-1 and 100s-1 respectively, (Levesque and Pike, 
2009)).  Theoretical analysis of a four pool model (analogous to Fig. 1a) has also shown 
that inter-compartmental exchange could substantially alter the estimated MWF, but that 
the qMT-based BPF is more robust (Levesque and Pike, 2009). In support of this 
theoretical analysis, much greater variation in MWF than BPF has been seen in the spinal 
cord, not only ex vivo (Dula et al., 2010) but also in vivo (Harkins et al., 2012).  The 
variability observed across tracts was consistent with variable exchange due to 
differences in axon diameter and myelin thickness, the key determinants of the g-ratio.  
Much of the extensive validation work for the MWI technique has been conducted ex vivo, 
and often with samples at room temperatures.  Both of these factors serve to slow the 
rate of exchange increasing the validity of the slow exchange assumption (Does, 2018). 
Therefore, one must again exercise caution extrapolating the validity of MWF metrics 
from ex vivo findings to the in vivo situation. 
Although these three and four pool models are likely to be closer to the true tissue 
microarchitecture, inversion of such a complex model would be difficult in terms of both 
precision and bias.  Indeed, even in the context of the two pool models that have been 
used to date for g-ratio mapping, the parameterisation must be supported by the data.  
The comparatively high parameterisation of the mcDESPOT model has necessitated the 
use of advanced fitting procedures, such as stochastic genetic or region contraction 
algorithms (Deoni et al., 2008, 2013).  The achievable precision and accuracy of the 
approach has been called into question (Lankford and Does, 2013; West et al., 2019) and 
it has been shown to suffer from degeneracy when seeking to determine optimal model 
parameters, which is only resolved by using a simpler model, excluding exchange (West 
et al., 2019).  A common requirement of all model types, including those capturing the 
AWF, is that any fixed parameters, e.g. as might be assumed in qMT models where the 
T1 of the free and bound pools may be assumed to be equal (Cabana et al., 2015), be 
appropriate to the population under consideration be they adults, children or indeed 
patients. 
While it is also incorrect to assume that the non-aqueous compartment of tissue is entirely 
comprised of myelin, this has been shown to be the dominant source of the MT contrast 
mechanism in WM  (Eng et al., 1991). In reality, the bound pool can be associated not 
only with the lipids and proteins of the myelin sheath, but also with any other 
macromolecule-bound protons (see Fig. 1a), e.g. glial cells (MacKay and Laule, 2016).  
MWF will not only capture water within myelin sheaths surrounding axons but also that 
associated with any myelin debris in pathological cases, as has been shown in peripheral 
nerve (Webb et al., 2003).  Similarly, MT-based measures lack specificity.  Hence it 
should be borne in mind that although alterations in myelin content will change the 
measured MT effect, an alteration in MT effects cannot be uniquely attributed to a change 
in myelin and may be driven by other macromolecular changes. The derived MVF is also 
used to correct for the fact that the diffusion signal is insensitive to this compartment (by 
rescaling AWF).  However, this neglects the non-myelin-macromolecular contribution 
within the imaging voxel, i.e. 𝑓𝐵𝑁𝑀  (Fig. 1a). 
Finally, MWF is most commonly estimated within the myelin-rich white matter but has 
been shown to be significantly lower in grey matter (MacKay et al., 2006; MacKay and 
Laule, 2016).  In this case, a further difficulty relates to whether or not sufficient sensitivity 
can be achieved in vivo to reliably estimate MWF in grey matter. 
 
3.1.2 AWF models 
Examples of strong simplifications used by the AWF models are that: the restricted 
compartment is solely associated with axons that can be modelled as impermeable sticks 
without cross-section, and that diffusion in the extra-cellular space is assumed to be 
Gaussian. The assumption that the restricted compartment is solely associated with 
axons is expected to be approximately correct in white matter because the density of 
other cells is small relative to the density of axons. In grey matter, however, the restricted 
diffusion signal will depend not only on the axonal compartment but on the density of cells 
of all types (soma and glia) as well. Thus, the simple three compartment approach of non-
CSF tissue stipulating that AVF+MVF+EVF=1, where the combination of one diffusion 
and one myelin biomarker can be used to estimate AVF, no longer holds because the 
diffusion biomarker derived from the restricted signal component will be weighted by both 
AVF and EVF.  
In addition to these model limitations, there is another problem associated with all of the 
approaches used for g-ratio mapping to date: they are based on the standard model 
comprised of compartments accounting for restricted and hindered diffusion.  This model 
is known to suffer from a degeneracy of parameter estimates (Jelescu et al., 2016a) when 
measured with a linear diffusion weighting approach, i.e. the typical Stejskal and Tanner 
(Stejskal and Tanner, 1965) diffusion weighting scheme, which has been the case for all 
the aforementioned g-ratio mapping studies.  
Alternatively, prior assumptions motivated by the biological composition of the tissue can 
be imposed to stabilize the parameter estimation. The NODDI, mcSMT, and WMTI 
models make particularly strong use of prior assumptions to allow the remaining model 
parameters to be estimated from data that can be acquired in a clinically feasible imaging 
time (see section 2.3.3). NODDI and mcSMT use a tortuosity model (Szafer et al., 1995) 
to relate the perpendicular extra-axonal diffusivity to the parallel extra-axonal diffusivity 
scaled by “one minus the neurite density”: (𝐷𝐸,⊥ = (1 − 𝜈)𝐷𝐸,||), i.e. the higher the neurite 
density in the tissue the lower the perpendicular diffusivity. As discussed in (Jelescu et 
al., 2015), the tortuosity model, however, should relate extra-axonal diffusivities to the 
extra-cellular space (𝐸𝑉𝐹 = 1 − 𝐹𝑉𝐹) rather than signal fraction of the hindered 
compartment, 𝜈. In other words, the relationship between the parallel and perpendicular 
extra-cellular diffusivities should effectively be: 𝐷𝐸,⊥ = (1 − 𝐹𝑉𝐹)𝐷𝐸,||. Moreover, NODDI 
and mcSMT impose a one-to-one scaling between the intra- and extra-cellular parallel 
diffusivities: 𝐷𝐴,|| = 𝐷𝐸,||. While mcSMT estimates the remaining diffusivity, NODDI fixes it 
to a constant value (for in vivo healthy adults the diffusivities are usually assumed to 
be: 𝐷𝐴,|| = 𝐷𝐸,|| =
1.7𝜇𝑚2
𝑚𝑠
 and 𝐷0 =
3𝜇𝑚2
𝑚𝑠
). This latter assumption would be problematic if 
different populations were studied, for which these diffusivities were not applicable, e.g. 
children, patients, or postmortem brains. WMTI, on the other hand, assumes that all fibres 
are aligned in parallel restricting its application to anatomical regions that support this 
assumption, e.g., it has been applied to the corpus callosum (West et al., 2018a). But, 
even in the corpus callosum axons are not necessarily aligned fully in parallel. This might 
be another reason (in addition to fixed diffusivities used in NODDI) for the systematically 
smaller AWF estimates when using WMTI as compared to NODDI as reported, e.g., in 
(Jelescu et al., 2015). Of course, this list of model assumptions that should be borne in 
mind is not exhaustive (Jelescu and Budde, 2017; Novikov et al., 2019). The Watson 
distribution used in NODDI can model fibre dispersion in a single fibre population, but 
cannot describe more complex fibre scenarios, such as crossing fibres. Nevertheless, it 
accounts, to a certain degree, for the variability of fibre-alignment within fibre pathways 
and thus might be better suited for whole brain g-ratio mapping than models that assume 
strictly parallel fibre configurations. 
 
3.2 Calibration for MVF 
Assuming that the diffusion-based AWF is accurate3, the relation between the myelin 
biomarker and the MVF still needs to be established via a calibration step. This calibration 
is particularly important since it is not only required to quantify the MVF, but also to convert 
                                                          
3 This assumption is probably wrong – see model validity in section 3.1.  
the AWF to AVF (Eq. 2).  Histological investigations suggest that the relationship between 
typical myelin biomarkers (which we will collectively denote 𝑀𝑀𝑅𝐼 in this section) and the 
MVF is linear (Fig. 4, (West et al., 2018b)):  
(3) 𝑀𝑉𝐹𝑀𝑅𝐼 = 𝛼𝑀𝑀𝑅𝐼 + 𝛽,  
where 𝛼 and 𝛽 are unknown coefficients that need to be calibrated. It is expected that 
these coefficients will depend on instrumental variables and may therefore vary with MR 
systems, sequence parameters, as well as myelin biomarker models. Such dependency 
clearly limits the reproducibility and comparability of the MR-based g-ratio. Using 
simulations, Campbell et al. (2018) demonstrated that imperfect calibration can not only 
introduce a bias in the g-ratio, but can even cause the g-ratio to depend on the fibre 
volume fraction, negating the major strength of the g-ratio, i.e. that it is independent of 
FVF. Their simulations revealed that this dependence was different if the miscalibration 
was present only in the offset or only in the slope and coined the phrase aggregated g-
ratio weighted imaging (Campbell et al., 2018).  
To reduce these dependencies, two calibration methods have been used for in vivo g-
ratio mapping.  These have utilised a region of interest (ROI) in which either (a) the myelin 
biomarker was calibrated against the reference 𝑀𝑉𝐹, first employed by (Stikov et al., 
2015) or (b) the measured g-ratio was calibrated against the reference g-ratio, first 
employed by (Mohammadi et al., 2015). We refer to these approaches collectively as 
single-point calibration methods since both are calibrating against a single reference 
value. Reformulating Eq. 3 within a specific ROI, it is clear that the single-point calibration 
methods estimate one effective proportionality constant (𝛼𝑒𝑓𝑓), i.e.:  
(4) 𝑀𝑉𝐹𝑀𝑅𝐼(𝑅𝑂𝐼, 𝛼𝑒𝑓𝑓) = (𝛼 +
𝛽
𝑀𝑀𝑅𝐼(𝑅𝑂𝐼)
) 𝑀𝑀𝑅𝐼(𝑅𝑂𝐼) ≡ 𝛼𝑒𝑓𝑓(𝛼, 𝛽, 𝑀𝑀𝑅𝐼) 𝑀𝑀𝑅𝐼(𝑅𝑂𝐼). 
From Equation (4) it is clear that the single-point calibration methods are insufficient to 
establish a one-to-one correspondence between the MVF and the MRI-based myelin 
biomarker. One problem, for example, could be that 𝛼𝑒𝑓𝑓  will depend on the myelin 
biomarker within the reference ROI if 𝛽 ≠ 0 (see Eq. (4)). The MVF-based single-point 
calibration method would simply set Equation 4 to a reference MVF value within the ROI: 
𝑀𝑉𝐹𝑀𝑅𝐼(𝑅𝑂𝐼, 𝛼𝑒𝑓𝑓,𝑜𝑝𝑡) = 𝑀𝑉𝐹𝑅𝐸𝐹 and rearrange the equation with respect to 𝛼𝑒𝑓𝑓,𝑜𝑝𝑡. The 
g-ratio based single-point calibration would minimize the following equation: 
(5) 𝛼𝑒𝑓𝑓,𝑜𝑝𝑡 = min
𝛼𝑒𝑓𝑓
‖𝑔(𝛼𝑒𝑓𝑓, 𝑅𝑂𝐼) − 𝑔𝑅𝐸𝐹(𝑅𝑂𝐼)‖  
with 𝑔(𝛼𝑒𝑓𝑓 , 𝑅𝑂𝐼) = √1 −
𝑀𝑉𝐹𝑀𝑅𝐼(𝑅𝑂𝐼,𝛼𝑒𝑓𝑓)
𝑀𝑉𝐹(𝑅𝑂𝐼,𝛼𝑒𝑓𝑓)+(1−𝑀𝑉𝐹(𝑅𝑂𝐼,𝛼𝑒𝑓𝑓))𝐴𝑊𝐹(𝑅𝑂𝐼)
 where 𝑔𝑅𝐸𝐹(𝑅𝑂𝐼) and 
𝐴𝑊𝐹(𝑅𝑂𝐼) are the reference g-ratio and the measured AWF values within the ROI 
respectively. 
The key questions that ensue from this single-point calibration are: what are the typical 
magnitudes of the slope 𝛼 and offset 𝛽 in experimental conditions and therefore what is 
the magnitude of the error propagated by 𝛼𝑒𝑓𝑓,𝑜𝑝𝑡? How much does the MR-based g-ratio 
deviate from the ground truth? How large is this deviation relative to the expected dynamic 
range of the g-ratio, e.g. pathology-related differences? 
Although the simulations in (Campbell et al., 2018) improved our understanding of the 
pitfalls of g-ratio mapping, they did not directly answer these questions. However, 
experimental data from the Does lab (Kelm et al., 2016; West et al., 2018b, 2018a) could 
help answer these questions. In those experiments, the authors reported the changes of 
the g-ratio and the associated myelin-volume fractions in a range of mouse models 
spanning hypo- to hyper-myelination using both MRI and electron microscopy.  The MRI 
based data included three biomarkers of myelin content: MWF (𝑓𝑀𝑊𝐹), BPF, and MTV.  
Since in this case MTV was derived from the MWI experiment (i.e. with a multi-
compartment model) we denote it 𝑀𝑇𝑉𝑀𝑊𝐼.  In the following, we will use the range of 
reported values for MVF from histology, and AWF from diffusion MRI, to generate ground 
truth parameters for a subsequent simulation-based experiment.  
We will evaluate the bias and error between the ground truth g-ratio, 𝑔𝐺𝑇, and that 
obtained by calibrated MRI measures, 𝑔𝑀𝑅𝐼, using Bland-Altman analyses (Bland and 
Altman, 1986). The Bland-Altman plots (Fig. 5) depict the difference (𝛿𝑔 = 𝑔𝐺𝑇 − 𝑔𝑀𝑅𝐼) 
between the g-ratios as a function of their mean (𝑚𝑔 = (𝑔𝐺𝑇 + 𝑔𝑀𝑅𝐼)/2). The solid line 
indicates the mean difference 〈𝛿𝑔〉, while the dashed lines indicate 〈𝛿𝑔〉 plus/minus 1.96 
times the standard deviation of the differences 〈𝑠𝑡𝑑𝛿𝑔〉 to encompass 95% of the normal 
distribution. According to their original publication (Bland and Altman, 1986), 〈𝛿𝑔〉  and 
+/−1.96 〈𝑠𝑡𝑑𝛿𝑔〉 can respectively be interpreted as the bias and error that would result if 
replacing 𝑔𝐺𝑇 with 𝑔𝑀𝑅𝐼. Bias captures the offset from the ground truth g-ratio value, 
whereas error captures the deviation from a one-to-one relationship between the ground 
truth and the MR g-ratio. While a potential bias can be retrospectively corrected, the error 
in the g-ratio mapping method will define its sensitivity and ability to detect change or 
differences between individuals, groups or over time. Any error must be lower than the 
expected difference between groups or due to pathology if the g-ratio mapping method 
using MRI is to be of use to reliably assess these differences. 
 
3.2.1 Ex vivo simulation experiment 
To generate a realistic range of ground truth values for the MVF and AWF, we used the 
histology-based MVF values reported in (West et al., 2018b), which range from 
approximately 0.015 to 0.285 (cf. Fig. 7 in (West et al., 2018b)) and the MRI-based AWF 
values as reported in (Kelm et al., 2016), ranging from approximately 0.3 to 0.7 (cf. Fig. 
13 in (Kelm et al., 2016)). Note all measurements are derived from the same animals. 
Then, we used Eqs. (1) and (2) to generate the ground truth g-ratio values (𝑔𝐺𝑇, which 
ranged from 0.79 to 0.97) 4. To generate the MRI-based myelin marker, we used the linear 
relationships reported in (West et al., 2018b) between the histological MVF (here: the 
ground truth MVF) and three myelin biomarkers: 𝐵𝑃𝐹 = 0.45 𝑀𝑉𝐹 + 0.086 (Fig. 4a 5), 
𝑓𝑀𝑊𝐹 = 0.89 𝑀𝑉𝐹 − 0.016 (Fig. 4b), and 𝑀𝑇𝑉𝑀𝑊𝐼 = 0.75 𝑀𝑉𝐹 − 0.047 (Fig. 4c 
6). Note 
that the calibration of 𝑀𝑊𝐹 was independent of the experimental data in (West et al., 
2018b) but based on literature values from an independent experiment. Therefore, 𝑓𝑀𝑊𝐹 
was used in the following simulations instead of 𝑀𝑊𝐹. This was opposite to the calibrated 
𝐵𝑃𝐹 , which was estimated using the experimental data in (West et al., 2018b). Also note 
that the 𝑀𝑇𝑉𝑀𝑊𝐼 requires an intrinsic calibration to normalize the water content (see 
section 2.2.1).  
In this simulation experiment, we compared 𝑔𝐺𝑇 with the non-calibrated g-ratio values 
(𝑔𝑀𝑅𝐼
𝑛𝑜𝑛𝑒) and with the calibrated g-ratio values (𝑔𝑀𝑅𝐼
𝑆𝑃𝐶) using either the g-ratio (Fig. 5b,e) or 
MVF (Fig. 5c,f) single-point calibration (SPC) methods (depicted as scatter in Fig. 5a-c 
and Bland-Altman plots in Fig. 5d-f). The SPC-reference values were based on the 
                                                          
4 Note that these values are larger than the g-ratios assessed via ex vivo histology in (West et al., 
2018a), ranging from 0.75 to 0.88. This may be because the latter was determined from 
myelinated axons only. The g-ratios in this simulations, however, are based on the combination 
of histological MVF and diffusion MRI-based AWF. The diffusion-based AWF should be sensitive 
to both myelinated and unmyelinated axons (Beaulieu and Allen, 1994a; Beaulieu, 2002). Since 
the g-ratio of unmyelinated axons is 1, a larger ground truth g-ratio is expected than the EM-
based values in (West et al., 2018a).  
5 Note that the linear equation reported in Figure 7 (West et al., 2018b) had a negative offset, 
i.e.: 𝐵𝑃𝐹 = 0.45 𝑀𝑉𝐹 − 0.086. But, this is assumed to be in error since it must be positive to 
describe the black curve.  
6 This linear equation was generated from the normalized water content estimated from 𝑀𝑊𝐼 
reported in Figure 8 (West et al., 2018b) and the conversion to 𝑀𝑇𝑉𝑀𝑊𝐼 was done according to 
(Berman et al., 2018).  
average in control mice (blue symbols in Fig. 7 (West et al., 2018b): 𝑀𝑉𝐹𝑅𝐸𝐹 ≈ 0.175 and 
𝑔𝑅𝐸𝐹 ≈ 0.85). The index 𝑀𝑅𝐼 described the myelin biomarker that was used to generate 
the g-ratio: i.e. 𝑔𝐵𝑃𝐹 used 𝐵𝑃𝐹 (blue crosses), 𝑔𝑓𝑀𝑊𝐹 used 𝑓𝑀𝑊𝐹 (green crosses), and 
𝑔𝑀𝑇𝑉𝑀𝑊𝐹 used 𝑀𝑇𝑉𝑀𝑊𝐼 (black crosses). When calculating the g-ratios, an upper and lower 
limit was applied meaning that if 𝑔𝑀𝑅𝐼
2 > 1, the g-ratio value was set to one (because 
(1 −
𝑀𝑉𝐹
𝐹𝑉𝐹
) ≤ 1) and if 𝑔𝑀𝑅𝐼
2 < 0, the g-ratio was set to zero (because (1 −
𝑀𝑉𝐹
𝐹𝑉𝐹
) ≥ 0). In 
the results, we report the bias and error of the Bland-Altman analyses relative to the 
dynamic range of simulated ground truth g-ratios: 𝑔𝑑𝑦𝑛 = max(𝑔𝐺𝑇) − min(𝑔𝐺𝑇) = 0.18.  
 
 
Figure 4: Depicted are the linear relations between the myelin-volume fraction (MVF) from gold 
standard electron microscopy and three MRI-based biomarkers for myelin: (a) Bound Pool 
Fraction (𝐵𝑃𝐹) from quantitative magnetization transfer imaging, (b) calibrated Myelinated Water 
Fraction (𝑓𝑀𝑊𝐹) from myelin water imaging, (c) the Normalized Water Content (𝑁𝑊𝐶). The 
estimated linear relations (red boxes) are used in our simulation experiment (see section 3.1.1-
3.1.2). Macromolecular Tissue Volume (𝑀𝑇𝑉) was calculated from 𝑁𝑊𝐶 according to Berman et 
al. (Berman et al., 2018).  Modified and reproduced with permission from West et al. (West et al., 
2018b). 
 Figure 5: Depicted are scatter (a-c) and Bland-Altmann plots (d-f) of the ground truth (𝑔𝐺𝑇) and 
the MRI-based g-ratios using no calibration (a,d) or the single-point calibration approaches based 
on the g-ratio (b,e) or MVF (c,f) from a reference region of interest. The MRI-based g-ratios were 
calculated using different biomarkers for myelin: bound pool fraction (𝐵𝑃𝐹, blue crosses), 
calibrated myelin-water fraction (𝑓𝑀𝑊𝐹, green crosses), and macromolecular tissue volume (𝑀𝑇𝑉, 
black crosses). The Bland-Altman plots (Bland and Altman, 1986) assess the bias and error when 
seeking to replace the ground truth g-ratio with the MRI-based measures. The plots depict the 
difference (𝛿𝑔 = 𝑔𝐺𝑇 − 𝑔𝑀𝑅𝐼) against the mean (𝑚𝑔 = (𝑔𝐺𝑇 + 𝑔𝑀𝑅𝐼)/2) of 𝑔-ratios with the solid 
line indicating the mean difference 〈𝛿𝑔〉, and the dashed lines indicating 〈𝛿𝑔〉 plus/minus 1.96 times 
the standard deviation of the differences 〈𝑠𝑡𝑑𝛿𝑔〉. 
 
3.2.2 Simulation results 
The results are summarized in Figures 5 as well as in Table 2. Without calibration, we 
found that the bias was smallest for the BPF-based g-ratio (6.6%) and largest for the 
MTV-based g-ratio (-41.7%). The error was smallest for the MWF-based g-ratio (1.0%), 
moderate for the MTV-based g-ratio (7.1%) and largest for the BPF-based g-ratio 
(25.5%). Regardless of calibration method (i.e. MVF or g-ratio reference) the calibration 
reduced the bias for the MWF-based g-ratio (ca. -3%) and the MTV-based g-ratio (ca. -
8%) but increased it for the BPF-based g-ratio (ca. 11%). Importantly, the calibration 
increased the error for MWF-based (ca. 6%) and MTV-based (ca. 21%) g-ratios and had 
almost no effect on the BPF-based g-ratio. Altogether, the BPF-based g-ratio exhibited 
comparatively large error exacerbated by its significantly compressed dynamic range 
(𝑑𝑦𝑛𝑔𝐵𝑃𝐹 =
max(𝑔𝐵𝑃𝐹
𝑛𝑜𝑛𝑒)−min(𝑔𝐵𝑃𝐹
𝑛𝑜𝑛𝑒)
𝑔𝑅𝐸𝐹
≈2%) as compared to the g-ratios using the other MVF 
proxies: 𝑑𝑦𝑛𝑔𝑀𝑊𝐹 ≈ 25%, 𝑑𝑦𝑛𝑔𝑀𝑇𝑉 ≈ 29%, 𝑑𝑦𝑛𝑔𝐺𝑇 ≈ 21%. Note that the abrupt change in 
the slopes of the MTV-based g-ratio values in Figs. 5 (black crosses) were due to reaching 
the upper limit for the MR g-ratio (i.e. the calibration led to a sealing effect for this 
biomarker).  
Calibration 𝐵𝑃𝐹 𝑓𝑀𝑊𝐹 𝑀𝑇𝑉 Reference 
value Bias 
[%] 
Error [%] Bias [%] Error [%] Bias [%] Error [%] 
none 6.6  25.5 −16.7 1.0 −41.7  7.1 − 
g-ratio 11.2 25.2 −2.7 5.9 −7.7 20.7 0.85 
MVF 11.3 25.2 −2.7 5.8 −7.8 20.7 0.175 
Table 2: The relative bias and error introduced by the g-ratio- based (3rd row) and MVF- based 
(4th row) single-point calibration as assessed by the Bland-Altman analysis for three different 
myelin biomarkers: Bound Pool Fraction (𝐵𝑃𝐹 in 2nd column), calibrated Myelin Water Fraction 
(𝑓𝑀𝑊𝐹 in 3
rd column), and Macromolecular Tissue Volume (𝑀𝑇𝑉 in 4th column). The reference 
values for the single-point calibrations are depicted in the last column. The bias and error are 
defined via the respective Bland-Altman analysis illustrated in Fig. 5. Bias is defined as the 
mean difference 〈𝛿𝑔〉. Error is defined as the interval between +/-1.96 〈𝑠𝑡𝑑𝛿𝑔〉 with 𝛿𝑔 = 𝑔𝐺𝑇 −
𝑔𝑀𝑅𝐼. Here, bias and error are presented in percentage, relative to the dynamic range of the 
ground truth g-ratios: 𝑔𝑑𝑦𝑛 = max(𝑔𝐺𝑇) − min(𝑔𝐺𝑇) = 0.18. 
 
3.2.3 What we can learn from the simulation experiment 
We learned from this simulation that the single-point calibration can reduce the bias in 
the g-ratio (i.e. two out of three MRI-based g-ratio values became closer to the ground 
truth) but it comes at the cost of an increased error (i.e. the deviation from a one-to-one 
correspondence between the MR and the ground truth g-ratio increased after calibration). 
We expect that the latter feature is of more relevance to typical g-ratio studies, where 
longitudinal changes in the g-ratio or changes in the g-ratio between groups will likely be 
investigated. Moreover, the simulations showed that 𝑓𝑀𝑊𝐹 and 𝑀𝑇𝑉𝑀𝑊𝐼 are reasonable 
biomarkers for the g-ratio in terms of their error. Perhaps surprisingly, they perform best, 
in terms of error, when no calibration is performed. 𝐵𝑃𝐹, on the other hand, is degraded 
as an MVF biomarker when using single-point calibration, but also suffers from larger 
error when no calibration is performed. Interestingly, the two better performing MVF 
biomarkers, i.e. 𝑓𝑀𝑊𝐹 and 𝑀𝑇𝑉𝑀𝑊𝐼, both involved a calibration step in their computation, 
unlike the 𝐵𝑃𝐹. For 𝑓𝑀𝑊𝐹 the calibration was purely based on literature values, whereas 
𝑀𝑇𝑉𝑀𝑊𝐼 was calibrated against a grey matter value specific to each brain.  
Based on these simulations, a number of conclusions can be drawn. First, the single-
point calibration method is insufficient to calibrate the g-ratio for the investigated 
scenarios where the offset parameter was non-zero. Second, at least in contexts 
consistent with those investigated here (e.g. fixed tissue, ex vivo MRI, mice),  𝐵𝑃𝐹-based 
g-ratio should not be used without more sophisticated calibration methods that are 
capable of accurately estimating both the slope and offset (see, e.g., (West et al., 2018b)). 
Third,  𝑓𝑀𝑊𝐹 and 𝑀𝑇𝑉𝑀𝑊𝐼 might be better biomarkers for g-ratio weighted imaging 
because they can be readily used without calibration. Some important caveats to these 
conclusions are outlined in the following. 
Since gold standard information is missing when investigating in vivo data, we have used 
ex vivo data to generate ground truth data for a simulation experiment. It is important to 
bear in mind that the presented results may not translate to the in vivo case because of 
potentially different model validity (see section 3.1.1). Data quality can also vary 
considerably between in vivo and ex vivo imaging scenarios.  Not only because of the 
use of fixed tissue ex vivo (and concomitant mitigation of physiological and motion 
corruption as well as the capacity for markedly longer scanning protocols) but also 
because of the different MRI techniques and non-clinical imaging systems used (West et 
al., 2018b). As a consequence, the relative differences in performance and impact of 
calibration for each of the g-ratios derived from different myelin biomarkers (𝐵𝑃𝐹, 𝑓𝑀𝑊𝐹, 
and 𝑀𝑇𝑉𝑀𝑊𝐹) should be interpreted with care. This important point is further emphasised 
in figure 6. This demonstrates that the small dynamic range in the 𝐵𝑃𝐹-based g-ratio 
relative to the 𝑀𝑇𝑉𝑀𝑊𝐹-based g-ratio predicted by simulation (Fig. 6a), does not manifest 
in comparable in vivo g-ratio maps (𝑀𝑇𝑠𝑎𝑡-based vs. 𝑀𝑇𝑉-based in Fig. 6b). These in fact 
show a greater dynamic range for the MTsat-based g-ratio and higher correspondence 
between the two approaches after calibration. This contrasting observation might be due 
to the reasons outlined above, the use of somewhat different techniques in vivo and ex 
vivo, or due to fixation issues, e.g. fixation has been shown to strongly increase the 𝐵𝑃𝐹 
in normal appearing white matter (Schmierer et al., 2008).  
In summary, these simulations show that the single-point calibration, used in virtually all 
in vivo g-ratio mapping studies to date (Table 1), does not fully resolve the issue of 
converting MR proxies to the true MVF and can even increase bias and error in the g-
ratio estimates.  Therefore, further methodological development and validation is required 
to find the optimal means of ensuring the necessary validity and sensitivity of the MR g-
ratio. 
 Figure 6: Illustration of the inter-relation between MR g-ratios derived from magnetisation transfer 
imaging (a: simulated 𝑔𝐵𝑃𝐹) and (b,c: in vivo 𝑔𝑀𝑇𝑠𝑎𝑡) or from the macromolecular tissue volume 
(a: simulated 𝑔𝑀𝑇𝑉𝑀𝑊𝐼) and (b,c: in vivo 𝑔𝑀𝑇𝑉) for two scenarios: omitting (𝑔
𝑛𝑜𝑛𝑒) or using single-
point calibration (𝑔𝑆𝑃𝐶) with a reference of 𝑔𝑅𝐸𝐹 = 0.71 in the medullary pyramid, estimated from 
(Graf von Keyserlingk and Schramm, 1984). The dynamic ranges of the MR g-ratios observed in 
simulation ex vivo (a) or via in vivo measurement (b,c) are very different. In both cases, there is 
a shift towards the identity line after SPC, but with much greater agreement between the 
measures in vivo. The maps in subfigure (c), adapted with permission from (Ellerbrock and 
Mohammadi, 2018a), were acquired using the protocol described in the caption of Fig. 7. Note 
that the MR g-ratios (“g3” and “g4”) in the original publication were erroneous due to a reported 
mistake, see corrigendum  (Ellerbrock and Mohammadi, 2018b). Here, the correct maps are 
depicted. 
 
 
 
3.3 Unification of Multi-modal data  
The aggregated g-ratio weighted imaging approach combines two complementary MRI 
contrasts, sensitive to the axonal-water and myelin volume fractions respectively. Given 
that each quantitative MRI technique is typically vulnerable to a specific set of artefacts, 
the combination of multiple data types needs to take care not to amplify these artefacts 
such that they obscure or corrupt the quantity of interest.  For example, we have 
previously demonstrated that modality-specific spatial distortions, arising from 
inhomogeneous magnetic susceptibility distributions in the brain, can prevent voxel-wise 
spatial correspondence of the AWF and MVF proxies being achieved and lead to 
erroneous g-ratio estimates (Mohammadi et al., 2015). Even after correcting the 
susceptibility-induced distortions using dedicated tools (Ruthotto et al., 2012, 2013), 
residual misalignments between the EPI-based diffusion data and the gradient-echo 
based magnetisation transfer saturation maps can persist. The most obvious reason for 
residual misalignments is, of course, insufficient susceptibility distortion correction, but 
partial-volume effects in the EPI-based diffusion data associated with the typically lower 
spatial resolution, the EPI-readout, and eddy current distortions can also lead to lower 
white-matter tissue probability in the diffusion data relative to the MTsat map (Fig. 7). 
Here, we suggest combining the overlap between two modality-specific white-matter 
tissue probability maps (TPMs) to remove regions in the resulting g-ratio maps (Fig. 7a.v 
and 7b.v) that do not overlap between the two MRI contrasts, i.e. the region outside the 
red contours in Fig. 7a.iii and Fig. 7b.iii. In the example of Figure 7, the TPM was 
generated from the MTsat (Fig. 7a.iii and 7b.iii) and NODDI (Fig. 7a.iv and 7b.iv) map, 
respectively. 
 Figure 7: Depicted are whole brain views (a) (and magnifications (b)) of the aggregated g-ratio 
weighted map ((v): 𝑔𝑀𝑇/𝑁𝑂𝐷𝐷𝐼), its  constituting two qMRI maps: the calibrated myelin biomarker 
((i): 𝑀𝑇𝑠𝑎𝑡), the axonal-water fraction ((ii): 𝐴𝑊𝐹), as well as the associated white-matter tissue 
probability maps (P(WM)) based on 𝑀𝑇𝑠𝑎𝑡 ((iii): P(WM)𝑀𝑇𝑠𝑎𝑡) or 𝐴𝑊𝐹 ((iv): P(WM)𝐴𝑊𝐹). Although, 
a distortion-corrected 𝐴𝑊𝐹 maps with negligible residual distortions was used, P(WM)𝐴𝑊𝐹 is 
lower than the P(WM)𝑀𝑇𝑠𝑎𝑡 (see contours in the magnification (b)). To reduce artefactual g-ratio 
values in regions where one of the two constituent biomarkers is not defined, we suggest 
generating g-ratio values only in voxels where both tissue probabilities exceed a pre-defined 
threshold (here 0.5). Protocol details: 𝑀𝑇𝑠𝑎𝑡: the MPM (Weiskopf et al., 2013) protocol, including 
calibration (Lutti et al., 2012) and three different weightings (MT-, PD- and 𝑇1-weighting) SPGR 
images. The following sequence parameters were used: isotropic resolution of (1 mm)³, flip angle 
(FA) of 6° (for MT- and PD-weighted) and 21° (for T1-weighted), 8 echoes for PD- and T1-
weighted images (2.3 to 18.4 ms, in steps of 2.3 ms) and 6 echoes for MT-weighted images (2.3 
to 13.8 ms, in steps of 2.3 ms), readout bandwidth of 488 Hz/pixel, and repetition time (TR) of 
25.00 ms. Two successive runs of the above mentioned SPGR data were acquired using a 3D 
acceleration factor of 3 and partial Fourier (6/8) (total time: 28 min.); 𝐴𝑊𝐹: 3 shell DWI (b-values: 
500, 1000, 2500 mm/s2), each shell with 60 directions and additional b=0 images interspearsed, 
every 10 images, resolution: 1.6 mm isotropic, repetition time: 5300 ms, echo time: 73 ms. All 
scans were performed on a 3T PRISMA MRI (Siemens Healthcare, Erlangen, Germany), using 
the Siemens 1-channel transmitter (Tx) / 64-channel receiver (Rx) head-coil. The spatial 
distortions were reduced using the ACID toolbox (www.diffusiontools.com). 
 
3.4 Validation of g-ratio mapping 
Clear in vivo validation of g-ratio mapping is highly desirable, but generally unfeasible. 
We therefore typically rely on ex vivo histology for validation. A number of differences 
between these two imaging scenarios have been highlighted in previous sections.  Here 
we summarise key points specifically pertinent to the ex vivo histology (e.g. electron 
microscopy) gold standard scenario.  Most importantly, one has to consider the change 
in tissue composition that occurs when going from the in vivo to the ex vivo situation. 
In this case, the MRI signal and its parameters can significantly change due to, e.g. (i) 
autolysis (varying post-mortem interval (Shepherd et al., 2009)), (ii) fixation and the 
associated changes of cross-linking proteins, tissue shrinkage, and slowed diffusion 
processes (Schmierer et al., 2008; Shepherd et al., 2009), and (iii) temperature changes 
(Birkl et al., 2016). These changes affect diffusion (Dyrby et al., 2011) and other important 
MR parameters, such T1, T2* (Streubel et al., 2019) and susceptibility (based on signal 
phase) contrasts. However, despite these changes, the most important MRI mechanisms 
(e.g. diffusion anisotropy and relaxation mechanisms) are still present after fixation 
(Roebroeck et al., 2008). Nonetheless, it is necessary to characterize these differences 
in MRI parameters to enable translation and interpretation across in vivo and ex vivo 
measurements.  
 
3.4.1 g-ratio 
To date, only two studies have compared g-ratio measurements from ex vivo histology 
with MRI  (Stikov et al., 2015; West et al., 2018a). Stikov et al. (2015) compared the g-
ratio measured with in vivo MRI and ex vivo histology on a macaque monkey. West et al. 
(West et al., 2018a) compared g-ratio maps based on the WMTI, mcSMT and NODDI 
models to the equivalent g-ratio measured using gold standard histology techniques in 
mouse models. All three methods showed a moderate linear correspondence. It is 
important to note that for the NODDI model to work, the fixed diffusivities had to be 
adjusted empirically, suggesting that it is less well suited, at least for ex vivo data. Another 
interesting finding was that a simplified g-ratio model, in which the extra-axonal volume 
fraction was assumed to be one, such that AVF = 1 – MVF, performed equally well to the 
above mentioned diffusion signal models. The conclusions from this finding could be quite 
radical, i.e. that it is not necessary to measure both diffusion MRI and myelin markers to 
estimate changes in g-ratio across a strongly myelinating process. However, again 
caution is required since the gold-standard g-ratio (measured by histology) did not 
account for the contribution of unmyelinated axons, which the MRI g-ratio is also expected 
to depend on. Finally, it is important to highlight that, to date, no human specimen has 
been used to validate the g-ratio. This, however, would be a crucial step in linking ex vivo 
histology with our target in vivo application, i.e. g-ratio mapping in the human brain. 
 
3.4.2 MVF 
Here we discuss comparisons between myelin-sensitive MRI-based metrics and the gold 
standard MVF measured via histology that have been carried out in the context of g-ratio 
mapping. In early work, Stikov et al. compared the PSR estimated via MRI with the MVF 
estimated from electron microscopy (EM) in the corpus callosum of a macaque (Stikov et 
al., 2015). They found a linear dependence between these quantities but did not find the 
relationship to be significant, perhaps due to limited myelin-related variance present in 
the data.  Using mouse models spanning hypo- and hyper-myelinated conditions has 
allowed a broader variance in myelination to be investigated (West et al., 2018b).  West 
et al. used this approach to explore the relationship between the histological MVF, again 
derived from electron microscopy, and MRI-based measures in the same animals made 
using both MWI and qMT techniques (West et al., 2018b). They demonstrated a linear 
correlation between the MVF and both the MWF (r = 0.81) and the BPF (r = 0.84). Similar 
correlations were obtained between the MVF and the MR-derived equivalent, though the 
exact degree of correlation depended on the details of the calibration (Jung et al., 2018; 
West et al., 2018b).  Berman et al. (Berman et al., 2018) used data from the same study 
to explore the dependence of the MTV on MVF.  Unlike the typical quantification approach 
used in vivo, this ex vivo MTV measure was derived from a PD estimate obtained by 
extrapolating the MWI data to a TE of 0ms.  A linear dependence on MVF was also 
demonstrated for this ex vivo MTV measure (R2 = 0.74).  While these ex vivo observations 
of linear dependence of myelin-sensitive MR metrics on MVF lend credence to the 
calibration approach investigated in section 3.1, they nonetheless reinforce the need for 
calibration since none show an offset-free 1:1 relationship.  The previously outlined 
caveats regarding the translation of the methods from ex vivo to in vivo experiments must 
also be borne in mind.  
 
3.4.3 AVF 
Validation of AVF presents some distinct challenges. The AVF estimate derived from 
diffusion-based metrics (either via FVF or AVF=(1-MVF)AWF) is sensitive to the pool of 
myelinated axons but also influenced by the unmyelinated axons (Beaulieu and Allen, 
1994a, 1994b; Beaulieu, 2009; Jones, 2010).  By contrast, gold standard EM-based 
assessment of volume fractions often focus on the myelinated axons only (Kelm et al., 
2016; West et al., 2018b, 2018a; Zaimi et al., 2018; Tabarin et al., 2019). The myelin 
sheath provides protection against autolysis and acts as a contrast-enhancer for 
microscopy, making myelinated axons likely to be present and more easily detectible than 
unmyelinated axons (Olivares et al., 2001). In 2D EM, unmyelinated axons can also be 
confused with non-neuronal processes from cells like astrocytes or microglia. Ideally, a 
high-resolution microscopy approach combined with a neuron-specific stain, e.g. for 
neurofilaments, should be used to assess the AVF by encompassing all axons. (Jelescu 
et al., 2016b) compared MRI-based AWF with a histological counterpart (via Eq. (2)), 
including both myelinated axons and an estimate of unmyelinated axons, in mice models 
with different degrees of myelination. They found a linear relation, though not a 1:1 
correspondence. This is an indication that MRI-based AWF also needs to be calibrated. 
However, it is expected that miscalibration of AWF will have less effect on MR g-ratio than 
miscalibration of MVF because it has  been shown that (de)myelination-related changes 
in the g-ratio are strongly driven by changes in MVF and less so by the AWF (West et al., 
2018a). 
 
4 Conclusion and Outlook 
This review provides methodological background for the MRI techniques pertinent to 
aggregate g-ratio weighted mapping with the aim of improving understanding of the 
currently used biomarkers, as well as to provide insight into the potentials and particularly 
the pitfalls. G-ratio weighted mapping has the potential to achieve non-invasive mapping 
of this functionally-relevant microstructural parameter by utilising the strength of multi-
contrast quantitative MRI and biophysical models (also known as in vivo histology using 
MRI (Weiskopf et al., 2015)). The main take-home messages of this review are: (1) to 
fully benefit from the advantages of the aggregated g-ratio model, further work on a more 
appropriate calibration method is necessary to enable simultaneous estimation of both 
the slope and offset of the relationship between MRI markers and the true MVF; (2) more 
ex vivo histology gold standard measurements of human brain tissue are required to 
assess the typical range of MR g-ratio values that can be expected in vivo, (3) the quest 
to find the most appropriate MRI biomarkers for MVF and AVF for the in vivo situation is 
ongoing. In particular, there is currently a lack of validation studies for biomarkers of the 
AVF compartment using diffusion-based metrics. A major challenge here will be the 
estimation of the contribution to the AVF from unmyelinated axons (and cells potentially 
as well) via histology.   
Other models that combine WMTI parameters and fibre dispersion (as defined by Watson 
distribution, e.g., in NODDI) (Jelescu et al., 2015; Jespersen et al., 2018) might have the 
potential to combine the sensitivity of WMTI to compartmental diffusivities with the less 
strict assumption about fibre alignment of the NODDI model. However, they suffer from 
model-inherent degeneracies (Jelescu et al., 2016a). One proposed solution to this 
degeneracy is to combine linear encoding schemes with planar or spherical diffusion 
sequences (Reisert et al., 2018; Coelho et al., 2019). A few studies have compared the 
diffusion anisotropy and intra-cellular signal fraction from linear diffusion weighting with 
planar diffusion weighting sequences: (Henriques et al., 2019) did it ex vivo in mice and 
(Mohammadi et al., 2017) did it in vivo in humans. However, these techniques have not 
yet been used for aggregated g-ratio weighted imaging. Another study has revealed a 
one-to-one correspondence between a simplified NODDI model and the mean diffusivity 
and fractional anisotropy as measured with DTI (Edwards et al., 2017). NODDI-DTI might 
help to link the models of g-ratio mapping studies based on a standard DTI protocol to 
those models that were based on more advanced diffusion MRI protocols. However, it 
has also not yet been applied to g-ratio mapping either. Future directions might also 
include the use of generative signal models that directly depend on the MR g-ratio (e.g., 
(Wharton and Bowtell, 2012, 2013)) to allow its extraction, or alternatively estimating the 
g-ratio from a multi-compartment GRE signal model (Thapaliya et al., 2018, 2020). New 
approaches that promise greater specificity to myelin (e.g. ihMT (Varma et al., 2015; 
Ercan et al., 2018; Duhamel et al., 2019)) and intra-axonal (Shemesh et al., 2016) 
compartments may also improve our capacity to directly map the g-ratio in the human 
brain in vivo. 
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 Limitations of the AWF estimation approach (LA) 
LA.1 Assumes parallel fibres and thus can be applied only in regions where this 
assumption is not violated (typically it has been applied in the corpus 
callosum). 
LA.2 The TFD (Reisert et al., 2012) has been assumed to be proportional to the 
fibre volume fraction, neglecting the contribution of the myelin water. It relies 
on a tractography algorithm and thus inherits the associated limitations. G-
ratios based on this method show a larger scan-rescan variability as 
compared to NODDI-based g-ratios (Ellerbrock and Mohammadi, 2018a). 
LA.3 NODDI and mcSMT relate the perpendicular extra-axonal diffusivity to the 
parallel extra-axonal diffusivity scaled by “one minus the neurite density”: 
(𝐷𝐸,⊥ = (1 − 𝜈)𝐷𝐸,||). Moreover, NODDI and mcSMT impose a one-to-one 
scaling between the intra- and extra-cellular parallel diffusivities: 𝐷𝐴,|| = 𝐷𝐸,||. 
LA.4 NODDI fixes it to a constant value (for in vivo healthy adults the diffusivities 
are usually assumed to be: 𝐷𝐴,|| = 𝐷𝐸,|| =
1.7𝜇𝑚2
𝑚𝑠
 and 𝐷0 =
3𝜇𝑚2
𝑚𝑠
). 
LA.5 The WMTI model assumes parallel fibres and thus can applied only in regions 
where this assumption is not violated (typically it has been applied in the 
corpus callosum, but whether the model assumptions are sufficiently met 
there is unclear).  
LA.6 These studies provided not sufficient information to assess the specific 
implementation of the diffusion model. 
 Limitation of the MVF estimation approach (LM) 
LM.1 Requires a conversion factor to convert MRI-based myelin marker to the 
myelin volume fraction, which is done via histological data in different species. 
If this conversion factor is incorrect, the g-ratio will not be decoupled from the 
FVF (Stikov et al. 2015). 
LM.2 MTsat depends not only on the bound pool fraction but also on the rate of 
exchange, k, between the bound and free pools. Moreover it is a semi-
quantitative measure because it depends on the particular off-resonance 
pulse used in the sequence, most notably its power and offset frequency 
(Helms et al., 2008). 
LM.3 Results in biased (over-)estimates (West et al. 2019) with artifactually high 
precision (West et al. 2019; Lankford and Does, 2013). 
LM.4 Requires estimation of the proton density and therefore a normalisation factor, 
e.g. the proton density in CSF.  The optimal choice of the normalisation region 
will depend on the acquisition scheme, and will dictate the precision and 
accuracy of the MTV estimate. The modulation of the receiver coil’s sensitivity 
also needs to be removed, either by constrained model fitting or measurement 
(Mezer et al. 2016). 
LM.5 The MTR suffers from the same limitations as MTsat, but retains dependence 
on both T1 and transmit-field inhomogeneities. These additional 
dependencies make it more prone to error as demonstrated e.g. in (Callaghan 
et al., 2015). 
LM.6 When fitting magnitude multi-echo data with long echo times, significant 
biases can be introduced by the Rician noise distribution that can greatly alter 
the measured T2(*) values (Bjarnason et al. 2013). 
Fitting results are sensitive to the choice of TE and echo spacing, e.g. higher 
apparent T2(*) and smaller fractional contributions from short T2 species as 
the first echo is increased (Whittall et al., 1999; Cercignani et al., 2018). A 
broad range of echo times are required to fully characterise both long and 
short T2 components.   
Short echo times are required to acquire a signal with appreciable contribution 
from myelin, which is particularly problematic for gradient echo imaging due 
to the very short T2* of myelin. 
LM.7 Error can result from the sensitivity to B1+ effects, both inhomogeneity, which 
can lead to stimulated echoes distorting the decay, and slice profile effects for 
2D acquisitions (Lebel and Wilman, 2010).  Power deposition can also be 
problematic, particularly at UHF. 
LM.8 Sensitivity to B0 inhomogeneity can bias model fits (Nam et al. 2015a). Phase 
errors caused by breathing and eddy currents can also lead to errors if 
uncorrected (Nam et al. 2015b). 
LM.9 Assumes a two pool model, which is a simplification, but likely sufficient to be 
supported by in vivo data acquired in the human brain (Levesque and Pike, 
2009). 
LM.10 The model validity is unknown. 
TABLE A1: This table summarizes the limitation of MRI-based techniques for MVF and 
AWF (FVF) measurement. 
 
 
 
Table A2: MRI Methodological Abbreviations 
Myelin Imaging Techniques 
MWI Myelin Water Imaging 
MET2(*) Multi-Exponential fitting to map compartment-specific T2(*) 
qMT Quantitative Magnetisation Transfer 
bSSFP Balanced Steady State Free Precession 
SPGR SPoiled Gradient Recalled echo 
mcDESPOT 
Multi-Compartment Driven Equilibrium Single Pulse Observation of 
T1 and T2 
 
Diffusion Imaging Techniques 
DWI Diffusion Weighted Imaging 
DTI Diffusion Tensor Imaging 
NODDI Neurite Orientation and Dispersion Diffusing Imaging 
CHARMED Composite Hindered And Restricted Model of Diffusion 
WMTI White Matter Tissue Integrity 
TFD Tract Fibre Density 
mcSMT Multi-Compartment Spherical Mean Technique 
 
Biomarker and volume fractions 
BPF (f) Bound pool fraction 
Bound pool magnetisation relative to the 
combined bound and free pool 
magnetisation amplitudes as measured 
using qMT. 
PSR (F) Pool size ratio 
Bound pool magnetisation relative to free 
pool magnetisation amplitude as measured 
using qMT. 
AVF Axonal volume fraction 
The fraction of the imaging voxel volume 
that is intra-axonal. 
AWF Axonal water fraction 
The fraction of the MRI water signal 
originating from the axonal compartment. 
MVF Myelin volume fraction 
The fraction of the imaging voxel volume 
associated with myelin. This includes both 
the myelin itself and the water trapped 
between its bilayers. 
MWF Myelin water fraction 
The fraction of the MRI water signal 
identified as exhibiting faster relaxation 
and attributed to the water trapped within 
the myelin sheath. 
EVF 
Extra cellular volume 
fraction 
The fraction of the imaging voxel volume 
that originates outside the fibre. 
FVF Fibre volume fraction 
The fraction of the imaging voxel volume 
that originates outside the fibre. 
PD Proton density 
The concentration of MR-visible water 
relative to the concentration in the same 
volume comprised entirely of water. 
MTV(F) 
Macromolecular tissue 
volume (fraction) 
The (fractional) volume of the imaging 
voxel that is comprised of macromolecules, 
i.e. that is not MR-visible water.  
MTsat 
Magnetisation transfer 
saturation 
The steady state signal loss as a result of 
magnetisation transfer between the bound 
and free pools. 
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